Latest News

Published on 24/06/2019, 11:00 | 362hits
prestige-biopharma-reports-positive-top-line-phase-iii-results-for-tuznue-trastuzumab-biosimilar
Prestige BioPharma Reports Positive Top-Line Phase III Results for Tuznue® (Trastuzumab Biosimilar)
Published on 24/06/2019, 08:00 | 355hits
clinigen-broadens-partnership-with-accord-healthcare-to-supply-and-distribute-cardioxane-and-savene-in-poland
Clinigen Broadens Partnership with Accord Healthcare to Supply and Distribute Cardioxane® and Savene® in Poland
Published on 20/06/2019, 14:00 | 600hits
agendia-announces-publication-of-study-validating-use-of-mammaprint-and-blueprint-molecular-diagnostics-using-targeted-rna-next-generation-sequencing-technology
Agendia Announces Publication of Study Validating Use of MammaPrint and BluePrint Molecular Diagnostics using Targeted RNA Next-Generation Sequencing Technology
Published on 17/06/2019, 17:00 | 722hits
phase-2-trial-shows-efficacy-of-cytuvax-s-adjuvant-platform-technology
Phase 2 Trial Shows Efficacy of CyTuVax’s Adjuvant Platform Technology
Published on 17/06/2019, 09:00 | 737hits
osteolabs-gmbh-successfully-closes-seed-financing-round
Osteolabs GmbH Successfully Closes Seed Financing Round
Published on 11/06/2019, 14:00 | 1295hits
saga-raises-40-million-sek-3-7-million-to-advance-ultrasensitive-cancer-liquid-biopsies
SAGA Raises 40 Million SEK (€3.7 Million) To Advance Ultrasensitive Cancer Liquid Biopsies
Published on 05/06/2019, 14:45 | 1375hits
arivis-presents-the-new-vision4d-3-1-release-for-working-with-multi-dimensional-big-image-data
arivis Presents the New Vision4D 3.1 Release for Working with Multi-Dimensional Big Image Data
Published on 04/06/2019, 14:00 | 1116hits
strategic-collaboration-between-biotage-and-yingsheng-on-the-chinese-market-for-clinical-mass-spectrometry-applications
Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications
Published on 04/06/2019, 08:00 | 1249hits
apceth-will-operate-as-the-commercial-manufacturer-in-europe-for-zynteglo-bluebird-bio-s-gene-therapy-for-thalassemia
apceth Will Operate as the Commercial Manufacturer in Europe for Zynteglo™, bluebird bio’s Gene Therapy for β-Thalassemia
Published on 02/06/2019, 15:00 | 1019hits
sotio-s-dcvac-luca-significantly-improves-survival-in-patients-with-stage-iv-non-small-cell-lung-cancer
SOTIO’s DCVAC/LuCa Significantly Improves Survival in Patients with Stage IV Non-small Cell Lung Cancer
Published on 01/06/2019, 15:00 | 1153hits
blueprint-identifies-genomic-subtypes-for-african-american-breast-cancer-patients-with-low-risk-outcomes
BluePrint® Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes
Published on 28/05/2019, 17:10 | 1192hits
vetter-works-towards-a-sustainable-energy-supply
Vetter Works Towards a Sustainable Energy Supply
Published on 28/05/2019, 11:45 | 1808hits
european-medicines-agency-accepts-marketing-authorisation-application-for-prestige-biopharma-s-trastuzumab-biosimilar-hd201-for-review
European Medicines Agency Accepts Marketing Authorisation Application for Prestige BioPharma’s Trastuzumab Biosimilar HD201 for Review
Published on 23/05/2019, 10:00 | 1404hits
probiogen-and-abcuro-signed-glymaxx-improved-cell-line-development-and-gmp-production-agreement
ProBioGen and Abcuro Signed GlymaxX®-Improved Cell Line Development and GMP Production Agreement
Published on 21/05/2019, 20:00 | 1533hits
agendia-and-imegen-announce-an-exclusive-distribution-agreement-for-mammaprint-and-blueprint-in-spain-and-portugal
Agendia and Imegen Announce an Exclusive Distribution Agreement for MammaPrint® and BluePrint® in Spain and Portugal
Published on 21/05/2019, 08:30 | 1499hits
ime-medical-electrospinning-launches-medispin-xl-a-cutting-edge-high-volume-electrospinning-production-platform-for-medical-devices
IME Medical Electrospinning Launches MediSpin XL™, a Cutting-Edge High-Volume Electrospinning Production Platform for Medical Devices
Published on 20/05/2019, 12:00 | 1535hits
sotio-to-present-final-phase-i-ii-dcvac-luca-data-at-asco-2019-annual-meeting
SOTIO to Present Final Phase I/II DCVAC/LuCa Data at ASCO 2019 Annual Meeting
Published on 17/05/2019, 08:00 | 1470hits
cristal-therapeutics-to-present-data-at-the-american-society-of-clinical-oncology-asco-2019-annual-meeting-on-lead-clinical-candidate-cpc634-in-patients-with-solid-tumors
Cristal Therapeutics to Present Data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting on Lead Clinical Candidate CPC634 in Patients With Solid Tumors
Published on 15/05/2019, 10:00 | 1485hits
probiogen-and-vaccitech-sign-license-agreement-for-probiogen-s-technology-platform
ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform
Published on 14/05/2019, 09:00 | 2641hits
sensid-inks-distribution-agreement-with-tataa-biocenter-for-its-mdx-reference-standards
SensID Inks Distribution Agreement with TATAA Biocenter for its MDx Reference Standards
Published on 09/05/2019, 12:15 | 2212hits
new-ultra-convenient-solid-phase-extraction-disks-from-biotage
New Ultra Convenient Solid Phase Extraction Disks from Biotage
Published on 08/05/2019, 11:00 | 2244hits
sartorius-stedim-biotech-introduces-new-simca-16-software-for-multivariate-data-analytics
Sartorius Stedim Biotech Introduces New SIMCA® 16 Software for Multivariate Data Analytics
Published on 07/05/2019, 11:50 | 1229hits
esact-inaugural-innovation-award-to-honor-probiogen-s-cso-dr-volker-sandig
ESACT Inaugural Innovation Award to Honor ProBioGen’s CSO Dr. Volker Sandig
Published on 07/05/2019, 10:00 | 2296hits
wise-enrols-first-patient-in-pivotal-clinical-study-of-novel-neuro-electrodes-for-brain-monitoring
WISE Enrols First Patient in Pivotal Clinical Study of Novel Neuro-Electrodes for Brain Monitoring
Published on 02/05/2019, 14:30 | 3284hits
sartorius-stedim-biotech-launches-new-ambr-15-cell-culture-microbioreactor-system
Sartorius Stedim Biotech Launches New ambr® 15 Cell Culture Microbioreactor System
Published on 02/05/2019, 10:00 | 1953hits
amal-therapeutics-enters-clinical-collaboration-with-boehringer-ingelheim-to-evaluate-atp128-in-combination-with-bi754091
AMAL Therapeutics Enters Clinical Collaboration with Boehringer Ingelheim to Evaluate ATP128 in Combination with BI754091
Published on 29/04/2019, 10:00 | 3105hits
implandata-successfully-gains-ce-mark-for-its-eyemate-system-for-an-orphan-eye-indication
Implandata Successfully Gains CE Mark for its EYEMATE System for an Orphan Eye Indication
Published on 25/04/2019, 09:00 | 2996hits
shuwen-presents-at-the-2nd-companion-diagnostic-i-o-biomarker-conference-in-shanghai
Shuwen Presents at The 2nd Companion Diagnostic & I-O Biomarker Conference in Shanghai
Published on 24/04/2019, 18:45 | 1718hits
new-data-show-blueprint-identifies-estrogen-receptor-positive-breast-cancer-patients-with-poor-response-to-anti-estrogen-therapy-who-may-benefit-from-neoadjuvant-chemotherapy
New Data Show BluePrint® Identifies Estrogen Receptor Positive Breast Cancer Patients with Poor Response to Anti-Estrogen Therapy Who May Benefit from Neoadjuvant Chemotherapy
Published on 24/04/2019, 09:00 | 2279hits
velabs-therapeutics-to-cooperate-with-chiome-bioscience-in-the-field-of-gpcr-specific-functional-antibody-screening
Velabs Therapeutics to Cooperate with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening
Published on 16/04/2019, 16:30 | 3700hits
vetter-s-skokie-facility-expansion-nears-completion
Vetter's Skokie Facility Expansion Nears Completion
Published on 28/03/2019, 12:00 | 5216hits
novel-first-in-class-flip-inhibitors-for-the-treatment-of-cancer
Novel First-In-Class FLIP Inhibitors for the Treatment of Cancer
Published on 28/03/2019, 10:00 | 7454hits
proteonic-biotechnology-licenses-protein-production-technology-to-bayer
ProteoNic Biotechnology Licenses Protein Production Technology to Bayer
Published on 28/03/2019, 09:30 | 5022hits
bcg-digital-ventures-and-sartorius-help-launch-the-world-s-first-voice-powered-digital-assistant-for-scientists
BCG Digital Ventures and Sartorius Help Launch the World’s First Voice-Powered Digital Assistant for Scientists
Published on 28/03/2019, 09:00 | 7157hits
tasly-pharmaceutical-group-taps-shuwen-biotech-for-companion-diagnostic-services
Tasly Pharmaceutical Group Taps Shuwen Biotech for Companion Diagnostic Services
Published on 27/03/2019, 14:45 | 4612hits
ambr-15-fermentation-and-ambr-250-high-throughput-systems-now-available-with-integrated-online-biomass-measurement-for-microbial-applications
ambr® 15 Fermentation and ambr® 250 High Throughput Systems Now Available with Integrated Online Biomass Measurement for Microbial Applications
Published on 26/03/2019, 09:00 | 2372hits
eur-3-million-in-series-a-for-the-growth-and-development-of-cytena-gmbh
EUR 3 Million in Series A for the Growth and Development of Cytena GmbH
Published on 25/03/2019, 09:00 | 5401hits
implandata-successfully-gains-ce-mark-for-next-generation-eyemate-system-and-poised-for-european-wide-market-launch
Implandata Successfully Gains CE Mark for Next-Generation EyeMate System and Poised for European-Wide Market Launch
Published on 22/03/2019, 09:00 | 4997hits
alzprotect-starts-collaboration-with-parexel-biotech-for-phase-2a-of-azp2006-for-the-treatment-of-progressive-supranuclear-palsy-psp
AlzProtect Starts Collaboration with PAREXEL Biotech for Phase 2a of AZP2006 for the Treatment of Progressive Supranuclear Palsy (PSP)
Published on 21/03/2019, 16:00 | 2542hits
customers-experience-leads-to-a-highly-successful-outcome-for-vetter-at-the-2019-cmo-leadership-awards
Customers’ Experience Leads to a Highly Successful Outcome for Vetter at the 2019 CMO Leadership Awards
Published on 21/03/2019, 10:00 | 5035hits
ab2-bio-announces-readiness-for-recruitment-in-pivotal-phase-3-trial-of-tadekinig-alfa-a-novel-human-recombinant-interleukin-18-binding-protein-in-children-with-genetic-diagnosis-of-nlrc4-mas-mutation-or-xiap-deficiency-with-amended-design-in-the-u-s
AB2 Bio Announces Readiness for Recruitment in Pivotal Phase 3 Trial of Tadekinig Alfa, a Novel Human Recombinant Interleukin-18 Binding Protein, in Children with Genetic Diagnosis of NLRC4-MAS Mutation or XIAP Deficiency, with Amended Design in the U.S.
Published on 21/03/2019, 09:00 | 4920hits
lead-pharma-announces-start-of-phase-i-clinical-trials-with-sar441169-candidate-treatment-for-psoriasis
Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis
Published on 20/03/2019, 08:00 | 4765hits
domainex-and-spirochem-enter-a-fragment-drug-discovery-partnership
Domainex and SpiroChem Enter a Fragment Drug Discovery Partnership
Published on 19/03/2019, 21:00 | 4979hits
sotio-s-dcvac-ovca-significantly-improves-survival-in-patients-with-recurrent-ovarian-cancer
SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer
Published on 18/03/2019, 10:00 | 2325hits
cellesce-announces-license-agreement-with-hubrecht-organoid-technology-hub-for-the-expansion-of-breast-cancer-organoids-at-scale
Cellesce Announces License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Breast Cancer Organoids at Scale
Published on 13/03/2019, 10:00 | 2575hits
deuterium-depletion-is-a-disruptive-innovation-in-the-pharma-industry-hyd-pharma-develops-new-deuterium-depleted-drugs-for-the-treatment-of-neoplastic-and-metabolic-diseases
Deuterium Depletion is a Disruptive Innovation in the Pharma Industry - HYD Pharma Develops New Deuterium-Depleted Drugs for the Treatment of Neoplastic and Metabolic Diseases
Published on 13/03/2019, 09:00 | 5126hits
nbe-to-present-late-breaking-abstract-on-lead-adc-program-nbe-002-ror1-at-the-aacr-annual-meeting
NBE to Present Late-Breaking Abstract on Lead ADC Program NBE-002 (ROR1) at the AACR Annual Meeting
Published on 08/03/2019, 14:30 | 3261hits
third-sartorius-research-xchange-forum-2019-focuses-on-car-t-cell-therapy
Third Sartorius Research Xchange Forum 2019 Focuses on CAR-T Cell Therapy
Published on 07/03/2019, 17:00 | 5092hits
potential-new-treatment-for-heart-attack
Potential New Treatment for Heart Attack
Published on 07/03/2019, 11:00 | 5445hits
sotio-to-present-final-phase-ii-dcvac-ovca-data-at-the-2019-sgo-annual-meeting-on-women-s-cancer
SOTIO to Present Final Phase II DCVAC/OvCa Data at the 2019 SGO Annual Meeting on Women's Cancer
Published on 05/03/2019, 15:00 | 3244hits
adult-stem-cell-derived-kidney-on-a-chip-in-nature-biotechnology
Adult Stem Cell-Derived Kidney-on-a-Chip in Nature Biotechnology
Published on 05/03/2019, 14:00 | 6076hits
sartorius-stedim-biotech-and-novasep-to-develop-novel-systems-for-membrane-chromatography
Sartorius Stedim Biotech and Novasep to Develop Novel Systems for Membrane Chromatography
Published on 04/03/2019, 08:00 | 5685hits
novago-therapeutics-raises-chf-10-million-to-develop-regenerative-anti-nogo-therapy-for-stroke
NovaGo Therapeutics Raises CHF 10 Million to Develop Regenerative Anti-Nogo Therapy for Stroke
Published on 01/03/2019, 08:00 | 9838hits
neurimmune-appoints-john-dellapa-as-general-counsel
Neurimmune Appoints John Dellapa as General Counsel
Published on 28/02/2019, 15:15 | 5721hits
confo-therapeutics-forms-scientific-advisory-board-as-it-accelerates-development-of-proprietary-drug-discovery-engine
Confo Therapeutics Forms Scientific Advisory Board as It Accelerates Development of Proprietary Drug Discovery Engine
Published on 27/02/2019, 09:00 | 6068hits
cac-and-rfxcel-announce-a-partnership-agreement-for-pharmaceutical-traceability
CAC and rfxcel Announce a Partnership Agreement for Pharmaceutical Traceability
Published on 20/02/2019, 10:00 | 5879hits
sapreme-technologies-in-a-6-8-m-eu-alliance-to-develop-an-oligonucleotide-delivery-platform-based-on-its-proprietary-endosomal-escape-enhancers
Sapreme Technologies in a 6.8 M€ EU Alliance to Develop an Oligonucleotide Delivery Platform Based on Its Proprietary Endosomal Escape Enhancers
Published on 20/02/2019, 09:00 | 4092hits
calypso-biotech-bv-secures-20-million-eur-in-series-a-financing-and-strengthens-team-to-develop-anti-il-15-therapeutic-antibody-for-autoimmune-diseases
Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases
Published on 20/02/2019, 08:00 | 6445hits
alzprotect-on-track-for-a-phase-2-entry-in-2019-for-its-drug-candidate-azp2006
AlzProtect, on Track for a Phase 2 Entry in 2019, for its Drug Candidate AZP2006
Published on 19/02/2019, 09:00 | 6408hits
rsp-systems-to-exhibit-its-cutting-edge-non-invasive-glucose-monitor-glucobeam-at-attd-2019
RSP Systems to Exhibit Its Cutting-Edge Non-Invasive Glucose Monitor, GlucoBeam at ATTD 2019
Published on 13/02/2019, 14:00 | 6020hits
haselmeier-acquires-drug-manufacturing-license-and-now-offers-assembly-labelling-and-packaging-services-to-pharmaceutical-and-biotechnology-companies
Haselmeier Acquires Drug Manufacturing License and Now Offers Assembly, Labelling and Packaging Services to Pharmaceutical and Biotechnology Companies
Published on 08/02/2019, 14:15 | 6839hits
andrew-alliance-and-sartorius-collaborate-to-provide-software-connected-pipettes-for-life-science-research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Published on 07/02/2019, 09:30 | 6939hits
cellmid-significant-new-findings-published-on-midkine
Cellmid: Significant New Findings Published on Midkine
Published on 05/02/2019, 13:00 | 9186hits
audion-therapeutics-and-regain-consortium-announce-positive-phase-i-results-in-patients-with-sensorineural-hearing-loss
Audion Therapeutics and REGAIN Consortium Announce Positive Phase I Results in Patients with Sensorineural Hearing Loss
Published on 05/02/2019, 12:00 | 6940hits
sotio-appoints-dr-harald-fricke-as-chief-medical-officer
SOTIO Appoints Dr. Harald Fricke as Chief Medical Officer
Published on 05/02/2019, 09:00 | 9616hits
proteonic-biotechnology-licenses-protein-production-technology-to-eli-lilly-and-company
ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly and Company
Published on 31/01/2019, 17:30 | 6776hits
sartorius-joins-the-community-of-the-national-institute-for-innovation-in-manufacturing-biopharmaceuticals-niimbl
Sartorius Joins the Community of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Published on 31/01/2019, 10:00 | 5435hits
hitachi-chemical-co-ltd-to-acquire-apceth-biopharma-gmbh
Hitachi Chemical Co. Ltd. to Acquire apceth Biopharma GmbH
Published on 24/01/2019, 10:00 | 7238hits
new-combined-diagnostic-and-antimicrobial-susceptibility-test-enables-resistance-guided-therapy-for-gonorrhoea
New Combined Diagnostic and Antimicrobial Susceptibility Test Enables Resistance-Guided Therapy for Gonorrhoea
Published on 23/01/2019, 14:40 | 7013hits
sartorius-stedim-biotech-offers-services-for-characterization-of-new-biological-entities-nbe
Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE)
Published on 22/01/2019, 13:30 | 7495hits
crispr-therapeutics-and-probiogen-sign-collaboration-and-license-agreement-to-develop-novel-in-vivo-delivery-technologies
CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies
Published on 22/01/2019, 13:30 | 7655hits
orchard-announces-publication-by-san-raffaele-telethon-institute-for-gene-therapy-of-otl-300-clinical-data-for-the-treatment-of-transfusion-dependent-beta-thalassemia-in-nature-medicine
Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature Medicine
Published on 21/01/2019, 13:30 | 7612hits
sartorius-stedim-biotech-introduces-biostat-rm-tx-with-flexsafe-rm-tx-for-producing-consistent-quality-cellular-products
Sartorius Stedim Biotech Introduces BIOSTAT® RM TX with Flexsafe® RM TX for Producing Consistent Quality Cellular Products
Published on 21/01/2019, 12:00 | 4934hits
minervax-announces-award-of-4-4-million-euro-in-investment-from-novo-holdings-repair-impact-fund-and-sunstone-capital-for-further-clinical-development-of-the-company-s-vaccine-against-group-b-streptococcus-gbs
MinervaX Announces Award of 4.4 Million Euro in Investment from Novo Holdings REPAIR Impact Fund and Sunstone Capital for Further Clinical Development of the Company’s Vaccine Against Group B Streptococcus (GBS)
Published on 10/01/2019, 14:00 | 5074hits
toxys-appoints-four-new-board-members-to-accelerate-business-growth
Toxys Appoints Four New Board Members to Accelerate Business Growth
Published on 10/01/2019, 09:00 | 7825hits
clinigen-extends-exclusive-european-clinical-trial-sourcing-and-supply-agreement-with-accord-healthcare
Clinigen Extends Exclusive European Clinical Trial Sourcing and Supply Agreement with Accord Healthcare
Published on 07/01/2019, 14:00 | 8392hits
orchard-therapeutics-highlights-recent-accomplishments-and-2019-strategic-priorities-as-a-global-leader-in-gene-therapy
Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy
Published on 07/01/2019, 09:00 | 7918hits
velabs-therapeutics-to-cooperate-with-biomed-x-in-the-field-of-immunology
Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology
Published on 14/12/2018, 13:30 | 8644hits
orchard-therapeutics-and-sirion-biotech-announce-licensing-agreement-to-enhance-gene-therapy-manufacturing-efficiency
Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
Published on 14/12/2018, 09:00 | 9721hits
prestige-biopharma-partners-with-cipla-ltd-to-market-key-cancer-biosimilar
Prestige BioPharma Partners with Cipla Ltd to Market Key Cancer Biosimilar
Published on 13/12/2018, 13:30 | 9085hits
orchard-therapeutics-announces-the-build-out-of-new-gene-therapy-manufacturing-facility-in-california
Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California
Published on 11/12/2018, 13:00 | 9067hits
batavia-biosciences-partners-with-iavi-to-advance-development-of-vaccine-against-lassa-fever
Batavia Biosciences Partners with IAVI to Advance Development of Vaccine Against Lassa Fever
Published on 07/12/2018, 13:30 | 9034hits
orchard-therapeutics-appoints-industry-veteran-alicia-secor-to-its-board-of-directors
Orchard Therapeutics Appoints Industry Veteran Alicia Secor to its Board of Directors
Published on 07/12/2018, 09:00 | 9322hits
shuwen-biotech-wins-at-the-7th-annual-china-innovation-and-entrepreneurship-competition
Shuwen Biotech Wins at the 7th Annual China Innovation and Entrepreneurship Competition
Published on 05/12/2018, 13:30 | 8833hits
donald-b-kohn-md-orchard-therapeutics-scientific-advisory-board-member-presents-clinical-proof-of-concept-data-for-otl-102-gene-therapy-for-the-treatment-of-patients-with-x-cgd-at-the-presidential-symposium-at-the-2018-ash-annual-meeting
Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting
Published on 04/12/2018, 09:30 | 9097hits
dr-irina-buhimschi-joins-shuwen-biotech-as-a-scientific-advisor
Dr. Irina Buhimschi Joins Shuwen Biotech as a Scientific Advisor
Published on 03/12/2018, 11:00 | 10067hits
first-patient-successfully-implanted-with-implandata-s-novel-eye-pressure-sensor-for-continual-glaucoma-monitoring
First Patient Successfully Implanted with Implandata’s Novel Eye Pressure Sensor for Continual Glaucoma Monitoring
Published on 28/11/2018, 12:00 | 9290hits
biontech-mammatyper-validated-as-predictor-for-response-after-neoadjuvant-chemotherapy-nact-in-patients-with-early-breast-cancer-bc
BioNTech: MammaTyper® Validated as Predictor for Response After Neoadjuvant Chemotherapy (NACT) in Patients with Early Breast Cancer (BC)
Published on 26/11/2018, 10:00 | 6532hits
immune-regulation-announces-positive-results-from-phase-1-clinical-trial-of-pin201104
Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104
Published on 21/11/2018, 18:00 | 9923hits
selvita-announces-presentations-on-cdk8-inhibitor-sel120-at-the-60th-american-society-of-hematology-annual-meeting
Selvita Announces Presentations on CDK8 Inhibitor SEL120 at the 60th American Society of Hematology Annual Meeting
Published on 19/11/2018, 09:00 | 9853hits
restoring-sight-clinical-progress-towards-australia-s-bionic-eye
Restoring Sight: Clinical Progress Towards Australia’s Bionic Eye
Published on 16/11/2018, 15:00 | 9728hits
elpis-biomed-wins-cambridge-start-up-of-the-year
Elpis Biomed Wins Cambridge Start-Up of the Year
Published on 15/11/2018, 09:00 | 9213hits
dr-anthony-tolcher-joins-the-scientific-advisory-board-of-nbe-therapeutics
Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics
Published on 14/11/2018, 12:00 | 9536hits
top-oncologist-dr-samuel-fourie-joins-advisory-board-of-azargen-biotechnologies
Top Oncologist, Dr Samuel Fourie, Joins Advisory Board of AzarGen Biotechnologies
Published on 12/11/2018, 10:00 | 9614hits
amal-therapeutics-finalises-29-million-chf-33-2-million-series-b-round
AMAL Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round
Published on 12/11/2018, 09:00 | 6812hits
retipharma-secures-funding-to-develop-treatments-of-degenerative-eye-disorders
RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disorders
Published on 09/11/2018, 18:00 | 8893hits
icosabutate-latest-data-shows-direct-and-potent-anti-fibrotic-effect-in-both-differentiated-rodent-nash-models-and-human-stellate-cells
Icosabutate Latest Data Shows Direct and Potent Anti-Fibrotic Effect in Both Differentiated Rodent NASH Models and Human Stellate Cells
Published on 09/11/2018, 14:45 | 8994hits
t3-pharmaceuticals-wins-prestigious-falling-walls-venture-award-for-its-bacterial-cancer-therapy
T3 Pharmaceuticals Wins Prestigious Falling Walls Venture Award for Its Bacterial Cancer Therapy
Published on 08/11/2018, 16:40 | 10120hits
selvita-to-present-new-data-from-sel120-program-at-eortc-nci-aacr-symposium-on-molecular-targets-and-cancer-therapeutics
Selvita to Present New Data from SEL120 Program at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Published on 08/11/2018, 15:40 | 16756hits
orchard-therapeutics-strengthens-global-commercial-leadership-team-with-appointments-of-heads-of-us-and-emea-region-commercial-operations
Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations
Published on 06/11/2018, 10:00 | 8923hits
probiogen-announces-successful-bispecific-glymaxx-development-project-for-zymeworks
ProBioGen Announces Successful Bispecific GlymaxX® Development Project for Zymeworks
Published on 05/11/2018, 13:00 | 6870hits
orchard-therapeutics-announces-closing-of-225-million-initial-public-offering-including-the-partial-exercise-of-underwriters-option
Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters' Option
Published on 31/10/2018, 14:30 | 8970hits
selvita-to-present-new-data-from-its-oncology-programs-at-the-upcoming-sitc-2018
Selvita to Present New Data from its Oncology Programs at the Upcoming SITC 2018
Published on 31/10/2018, 08:45 | 9110hits
orchard-therapeutics-announces-pricing-of-initial-public-offering
Orchard Therapeutics Announces Pricing of Initial Public Offering
Published on 25/10/2018, 16:00 | 9976hits
elpis-biomed-human-cell-models-could-potentially-replace-animal-experiments-in-drug-discovery
Elpis Biomed Human Cell Models Could Potentially Replace Animal Experiments in Drug Discovery
Published on 25/10/2018, 09:00 | 9332hits
cristal-therapeutics-initiates-phase-2-clinical-trial-of-innovative-cripec-nanomedicine-drug-candidate-in-ovarian-cancer
Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec® Nanomedicine Drug Candidate in Ovarian Cancer
Published on 24/10/2018, 15:45 | 6588hits
vetter-further-expands-secondary-packaging
Vetter Further Expands Secondary Packaging
Published on 22/10/2018, 13:00 | 9679hits
change-of-company-name-vtu-technology-is-now-validogen
Change of Company Name: VTU Technology is now VALIDOGEN
Published on 22/10/2018, 09:15 | 9292hits
polyganics-initiates-first-in-human-trial-of-liqoseal-its-innovative-approach-for-dural-closure
Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure
Published on 19/10/2018, 13:30 | 7757hits
apceth-biopharma-presents-positive-data-demonstrating-efficacy-of-apceth-201-in-preclinial-models-of-acute-gvhd
apceth Biopharma Presents Positive Data Demonstrating Efficacy of apceth-201 in Preclinial Models of Acute GvHD
Published on 11/10/2018, 09:30 | 10235hits
ime-medical-electrospinning-enters-into-development-cooperation-with-leading-chinese-medical-devices-company-amor-medical
IME Medical Electrospinning Enters into Development Cooperation with Leading Chinese Medical Devices Company Amor Medical
Published on 11/10/2018, 09:00 | 10033hits
not-just-for-pharma-anymore-rfxcel-extends-track-trace-solutions-to-food-beverage
Not Just for Pharma Anymore: rfxcel Extends Track & Trace Solutions to Food & Beverage
Published on 08/10/2018, 14:00 | 7339hits
tfs-collaboration-with-lobsor-pharmaceuticals-ab-on-the-development-of-lecigon-has-resulted-in-marketing-authorization-of-lecigon-in-sweden
TFS Collaboration with Lobsor Pharmaceuticals AB, on the Development of Lecigon®, Has Resulted in Marketing Authorization of Lecigon® in Sweden
Published on 05/10/2018, 12:45 | 7633hits
apceth-to-manufacture-first-potential-one-time-gene-therapy-for-transfusion-dependent-beta-thalassemia
apceth to Manufacture First Potential One-Time Gene Therapy for Transfusion-Dependent Beta-Thalassemia
Published on 04/10/2018, 14:01 | 10182hits
orchard-therapeutics-receives-ema-prime-designation-for-otl-300-an-investigational-lentiviral-gene-therapy-for-the-treatment-of-transfusion-dependent-beta-thalassemia
Orchard Therapeutics Receives EMA PRIME Designation for OTL-300, an Investigational Lentiviral Gene Therapy for the Treatment of Transfusion-Dependent Beta-Thalassemia
Published on 04/10/2018, 09:30 | 10234hits
metp-pharma-introduces-nascum-plus-against-the-onset-of-air-pollution-induced-inflammation
MetP® Pharma Introduces Nascum®-Plus Against the Onset of Air Pollution-induced Inflammation
Published on 01/10/2018, 14:30 | 7523hits
new-flash-purification-system-and-columns-from-biotage
New Flash Purification System and Columns from Biotage
Published on 26/09/2018, 15:15 | 10188hits
vetter-grants-award-for-novel-idea-at-the-open-innovation-challenge-injection-2-0
Vetter Grants Award for Novel Idea at the Open Innovation Challenge – Injection 2.0
Published on 26/09/2018, 11:45 | 8164hits
transplantation-medicine-c-cit-sensors-to-provide-biosensors-for-ex-vivo-liver-perfusion-machine-of-wyss-zurich-project-liver4life
Transplantation Medicine: C-CIT Sensors to Provide Biosensors for Ex Vivo Liver Perfusion Machine of Wyss Zurich Project Liver4Life
Published on 20/09/2018, 08:00 | 10521hits
medtech-company-ime-medical-electrospinning-establishes-new-high-tech-production-facility-to-set-the-world-wide-standard-for-ground-breaking-regenerative-medicine-solutions
Medtech Company IME Medical Electrospinning Establishes New High-Tech Production Facility to Set The World Wide Standard for Ground Breaking Regenerative Medicine Solutions
Published on 18/09/2018, 14:30 | 10415hits
dominick-arena-joins-implandata-ophthalmic-products-gmbh-board-of-directors-as-chairman
Dominick Arena Joins Implandata Ophthalmic Products GmbH Board of Directors as Chairman
Published on 18/09/2018, 08:00 | 10294hits
neurimmune-achieves-milestone-in-collaboration-with-ono-pharmaceutical
Neurimmune Achieves Milestone in Collaboration with Ono Pharmaceutical
Published on 17/09/2018, 09:30 | 10438hits
shuwen-biotech-s-pd-l1-detection-kit-validated-in-clinical-trials-of-leading-drugs
Shuwen Biotech‘s PD-L1 Detection Kit Validated in Clinical Trials of Leading Drugs
Published on 10/09/2018, 09:00 | 8082hits
rsp-systems-adds-eur-3-85-million-in-a-second-closing-of-its-series-b-funding-round-increasing-the-round-total-to-eur-10-35-million
RSP Systems Adds EUR 3,85 Million in a Second Closing of its Series B Funding Round, Increasing the Round Total to EUR 10,35 Million
Published on 09/09/2018, 09:00 | 10651hits
menarini-will-bring-lunaphore-s-ultra-rapid-tissue-staining-solution-labsat-frozen-to-market
Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat™ Frozen to Market
Published on 05/09/2018, 13:45 | 7655hits
thrombolytic-science-initiates-phase-2-clinical-trial-of-its-novel-treatment-regimen-for-ischemic-stroke
Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke
Published on 04/09/2018, 17:30 | 13959hits
sartorius-stedim-biotech-and-repligen-corporation-partner-to-introduce-next-generation-perfusion-enabled-bioreactors
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors
Published on 30/08/2018, 12:00 | 10803hits
sotio-and-ppf-complete-acquisition-of-cytune-pharma
SOTIO and PPF Complete Acquisition of Cytune Pharma
Published on 29/08/2018, 12:15 | 10680hits
orchard-therapeutics-expands-leadership-team-with-appointments-of-head-of-corporate-communications-and-head-of-human-resources
Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources
Published on 20/08/2018, 09:00 | 10818hits
c-cit-sensors-single-use-cell-culture-in-situ-technologies-for-the-simultaneous-automated-and-continuous-monitoring-of-glucose-and-lactate-in-cell-cultures
C-CIT Sensors: Single-use Cell Culture In-situ Technologies for the Simultaneous Automated and Continuous Monitoring of Glucose and Lactate in Cell Cultures
Published on 16/08/2018, 09:00 | 11032hits
rfxcel-enhances-pharmaceutical-track-and-trace-solution-for-russia
rfxcel Enhances Pharmaceutical Track and Trace Solution for Russia
Published on 13/08/2018, 10:00 | 12692hits
orchard-therapeutics-announces-150-million-series-c-financing-to-advance-gene-therapy-pipeline
Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
Published on 07/08/2018, 09:30 | 11294hits
rsp-systems-is-awarded-the-iso-13485-2016-certification-from-lrqa-an-important-milestone-towards-ce-marking-and-product-launch
RSP Systems is Awarded the ISO 13485:2016 Certification from LRQA, an Important Milestone Towards CE Marking and Product Launch
Published on 02/08/2018, 10:00 | 10868hits
orchard-therapeutics-appoints-jon-ellis-to-board-of-directors
Orchard Therapeutics Appoints Jon Ellis to Board of Directors
Published on 02/08/2018, 09:00 | 11380hits
turkish-pharmaceutical-industry-leader-abdi-ibrahim-selects-rfxcel-for-fmd-compliance
Turkish Pharmaceutical Industry Leader, Abdi Ibrahim, Selects rfxcel for FMD Compliance
Published on 23/07/2018, 09:00 | 11618hits
azafaros-b-v-secures-seed-funding-to-develop-new-treatments-in-rare-metabolic-disorders
Azafaros B.V. Secures Seed Funding to Develop New Treatments in Rare Metabolic Disorders
Published on 19/07/2018, 14:45 | 21388hits
kite-and-gadeta-announce-strategic-collaboration-to-advance-gamma-delta-t-cell-receptor-technology-for-solid-tumors
Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors
Published on 19/07/2018, 09:30 | 11859hits
shuwen-biotech-s-clinical-lab-successfully-passes-biyearly-college-of-american-pathologists-audit
Shuwen Biotech's Clinical Lab Successfully Passes Biyearly College of American Pathologists Audit
Published on 17/07/2018, 11:30 | 13302hits
polares-medical-closes-a-25m-financing-to-enter-clinical-validation
Polares Medical Closes a $25M Financing to Enter Clinical Validation
Published on 17/07/2018, 09:00 | 12443hits
leon-nanodrugs-supports-takeda-in-a-feasibility-assessment-of-leon-s-proprietary-microjet-reactor-mjr-nano-technology
leon-nanodrugs Supports Takeda in a Feasibility Assessment of leon’s Proprietary MicroJet Reactor (MJR®) Nano-Technology
Published on 12/07/2018, 15:00 | 11711hits
antabio-completes-12-5m-series-a
ANTABIO Completes € 12.5M Series A
Published on 12/07/2018, 08:00 | 11460hits
immatics-enters-into-a-strategic-partnership-with-genmab-to-develop-next-generation-bispecific-cancer-immunotherapies
Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies
Published on 10/07/2018, 10:00 | 13471hits
probiogen-and-pionyr-immunotherapeutics-initiate-a-second-immuno-oncology-contract-development-and-manufacturing-project
ProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-oncology Contract Development and Manufacturing Project
Published on 09/07/2018, 10:00 | 13906hits
orchard-therapeutics-appoints-joanne-beck-ph-d-to-board-of-directors
Orchard Therapeutics Appoints Joanne Beck, Ph.D. to Board of Directors
Published on 02/07/2018, 10:00 | 14396hits
varmx-raises-12-5-million-to-develop-modified-blood-coagulation-factor-x-for-treating-severe-bleeding-in-patients-using-anti-coagulants
VarmX Raises € 12.5 Million to Develop Modified Blood Coagulation Factor X for Treating Severe Bleeding in Patients Using Anti-Coagulants
Published on 02/07/2018, 09:00 | 13959hits
abcam-merck-collaboration-produces-new-pd-l1-antibody-for-immuno-oncology-research
Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research
Published on 29/06/2018, 14:00 | 14825hits
aptamer-group-uk-biotech-business-raises-2-2m-investment
Aptamer Group: UK Biotech Business Raises $2.2M Investment
Published on 29/06/2018, 09:00 | 15283hits
orchard-therapeutics-appoints-jim-geraghty-as-chairman-of-its-board-of-directors
Orchard Therapeutics Appoints Jim Geraghty as Chairman of its Board of Directors
Published on 28/06/2018, 14:45 | 16035hits
prestige-biopharma-and-alvogen-announce-license-and-supply-agreement-to-commercialize-prestige-s-trastuzumab-biosimilar-hervelous-in-central-and-eastern-europe
Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe
Published on 28/06/2018, 11:00 | 13040hits
nbe-therapeutics-closes-a-chf-20-million-financing-by-novo-holdings-a-s
NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S
Published on 27/06/2018, 09:30 | 12942hits
mdxhealth-s-selectmdx-test-successfully-stratifies-men-who-may-benefit-from-mp-mri-for-prostate-cancer-diagnosis
MDxHealth's SelectMDx Test Successfully Stratifies Men Who May Benefit from mp-MRI for Prostate Cancer Diagnosis
Published on 26/06/2018, 11:00 | 28159hits
reapplix-positive-outcome-data-of-large-randomized-controlled-trial-presented-at-american-diabetes-association-scientific-sessions
Reapplix: Positive Outcome Data of Large Randomized Controlled Trial Presented at American Diabetes Association Scientific Sessions
Published on 26/06/2018, 10:00 | 15472hits
probiogen-and-nouscom-sign-license-agreement-for-probiogen-s-technology-platform
ProBioGen and Nouscom Sign License Agreement for ProBioGen’s Technology Platform
Published on 26/06/2018, 09:00 | 15338hits
inthera-bioscience-ag-expands-management-team-with-seasoned-professionals-and-secures-4-7-million-second-tranche-of-9-6-million-series-a-financing
Inthera Bioscience AG Expands Management Team with Seasoned Professionals and Secures €4.7 Million Second Tranche of €9.6 Million Series A Financing
Published on 21/06/2018, 09:00 | 13954hits
cellgenix-completed-first-step-of-facility-expansion-to-stay-on-top-of-the-increasing-demands-for-gmp-cell-culture-reagents
CellGenix Completed First Step of Facility Expansion to Stay on Top of the Increasing Demands for GMP Cell Culture Reagents
Published on 20/06/2018, 14:00 | 15875hits
tfs-international-appoints-dr-suzanne-pavon-as-executive-vice-president-quality-assurance
TFS International Appoints Dr Suzanne Pavon as Executive Vice President, Quality Assurance
Published on 19/06/2018, 07:30 | 18190hits
neural-analytics-inc-receives-ce-mark-for-its-robotic-ultrasound-system
Neural Analytics, Inc. Receives CE Mark for its Robotic Ultrasound System
Published on 15/06/2018, 09:30 | 16176hits
triple-digit-growth-in-emea-as-pharma-companies-embrace-rfxcel-s-full-service-approach-to-fmd-compliance
Triple Digit Growth in EMEA as Pharma Companies Embrace rfxcel’s Full-Service Approach to FMD Compliance
Published on 14/06/2018, 10:00 | 16450hits
clinigen-signs-exclusive-supply-distribution-agreement-with-lukare-for-elliotts-b-solution
Clinigen Signs Exclusive Supply & Distribution Agreement with Lukare for Elliotts B® Solution
Published on 12/06/2018, 10:30 | 14758hits
sartorius-stedim-biotech-and-siemens-sign-long-term-cooperation-agreement-in-the-area-of-automation
Sartorius Stedim Biotech and Siemens Sign Long-Term Cooperation Agreement in the Area of Automation
Published on 11/06/2018, 09:00 | 17439hits
rsp-systems-secures-series-b-funding-to-drive-its-non-invasive-glucose-monitor
RSP Systems Secures Series B Funding to Drive its Non-Invasive Glucose Monitor
Published on 07/06/2018, 16:20 | 16876hits
vetter-strikes-out-on-new-pathways-to-further-develop-the-injection-process
Vetter Strikes Out on New Pathways to Further Develop the Injection Process
Published on 07/06/2018, 09:00 | 17670hits
orchard-therapeutics-announces-appointments-of-marc-dunoyer-and-charlie-rowland-to-board-of-directors
Orchard Therapeutics Announces Appointments of Marc Dunoyer and Charlie Rowland to Board of Directors
Published on 03/06/2018, 16:50 | 18809hits
phase-ii-clinical-trials-of-dcvac-show-significant-benefit-for-patients-with-ovarian-and-lung-cancer
Phase II Clinical Trials of DCVAC Show Significant Benefit for Patients with Ovarian and Lung Cancer
Published on 01/06/2018, 17:30 | 18000hits
biotheranostics-announces-presentation-of-key-data-for-cancertype-id-and-breast-cancer-index-at-asco-annual-meeting-in-chicago
Biotheranostics Announces Presentation of Key Data for CancerTYPE ID® and Breast Cancer Index™ at ASCO Annual Meeting in Chicago
Published on 01/06/2018, 14:00 | 29353hits
ppd-and-neogenomics-forming-global-strategic-alliance-for-pathology-and-molecular-testing-solutions
PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions
Published on 31/05/2018, 10:00 | 18278hits
thrombolytic-science-to-participate-in-2018-bio-international-conference
Thrombolytic Science to Participate in 2018 BIO International Conference
Published on 30/05/2018, 13:30 | 17165hits
zai-lab-and-crescendo-biologics-enter-exclusive-worldwide-license-agreement-for-innovative-protein-therapeutics-for-inflammatory-indications
Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications
Published on 28/05/2018, 09:00 | 18940hits
shuwen-biotech-and-bliss-biopharmaceutical-partner-on-companion-diagnostics-for-cancer-drugs
Shuwen Biotech and Bliss Biopharmaceutical Partner on Companion Diagnostics for Cancer Drugs
Published on 24/05/2018, 13:00 | 18297hits
probiogen-announces-further-development-milestone-for-use-of-its-glymaxx-cancer-cell-killing-enhancement-antibody-technology-with-merus-n-v
ProBioGen Announces Further Development Milestone for Use of Its GlymaxX® Cancer Cell-Killing Enhancement Antibody Technology with Merus N.V.
Published on 24/05/2018, 12:15 | 16237hits
thrombolytic-science-to-present-at-the-15th-anglo-nordic-life-science-investor-conference
Thrombolytic Science to Present at the 15th Anglo Nordic Life Science Investor Conference
Published on 24/05/2018, 12:00 | 19442hits
sotio-starts-phase-i-ii-trial-of-dcvac-in-combination-with-oncos-102-the-targovax-adenovirus-based-immunotherapy
SOTIO Starts Phase I/II Trial of DCVAC in Combination with ONCOS-102: The Targovax Adenovirus Based Immunotherapy
Published on 24/05/2018, 11:30 | 16292hits
lunaphore-and-vitro-sign-collaboration-agreement-to-develop-ish-protocols-for-rna-dna-targets
Lunaphore and Vitro Sign Collaboration Agreement to Develop ISH Protocols for RNA/DNA Targets
Published on 24/05/2018, 10:00 | 16692hits
agendia-and-angsana-to-provide-breast-cancer-risk-of-recurrence-testing-with-mammaprint-and-blueprint-to-patients-in-southeast-asia
Agendia and Angsana to Provide Breast Cancer Risk-of-Recurrence Testing with MammaPrint® and BluePrint® to Patients in Southeast Asia
Published on 23/05/2018, 09:15 | 16607hits
rfxcel-covers-the-cost-of-emvo-onboarding-fees
rfxcel Covers the Cost of EMVO Onboarding Fees
Published on 23/05/2018, 09:00 | 20823hits
peptide-display-company-orbit-discovery-closes-6-9m-series-a-financing
Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing
Published on 22/05/2018, 10:00 | 18018hits
clinigen-and-mitsubishi-tanabe-initiate-european-managed-access-program-for-edaravone-to-treat-als
Clinigen and Mitsubishi Tanabe Initiate European Managed Access Program for Edaravone to Treat ALS
Published on 17/05/2018, 09:00 | 19660hits
shuwen-debuts-it-s-codar-arms-pcr-liquid-biopsy-technology-at-asco-2018
Shuwen Debuts it's CODAR-ARMS PCR Liquid Biopsy Technology at ASCO 2018
Published on 15/05/2018, 17:00 | 19941hits
new-insights-into-hookipa-s-therat-replicating-viral-vector-platform-published-in-immunity
New Insights into Hookipa’s TheraT® Replicating Viral Vector Platform Published in Immunity
Published on 15/05/2018, 09:00 | 17659hits
agendia-s-mammaprint-and-blueprint-breast-cancer-tests-selected-by-unicancer-for-french-patients
Agendia’s MammaPrint® and BluePrint® Breast Cancer Tests Selected by Unicancer for French Patients
Published on 14/05/2018, 11:00 | 19392hits
successful-first-series-c-round-closing-for-medical-device-company-implandata-ophthalmic-products-gmbh
Successful First Series C-Round Closing for Medical Device Company Implandata Ophthalmic Products GmbH
Published on 14/05/2018, 10:00 | 20230hits
emergex-awarded-innovate-uk-grant-to-progress-its-universal-and-pandemic-flu-vaccine
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu Vaccine
Published on 10/05/2018, 11:30 | 20478hits
new-uv-monitor-kit-for-large-scale-purification
New UV Monitor Kit for Large Scale Purification
Published on 08/05/2018, 09:00 | 21545hits
celonic-ag-appoints-soenke-brunswieck-as-vice-president-cell-gene-therapy
Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy
Published on 07/05/2018, 16:30 | 18550hits
abcam-and-shuwen-biotech-sign-strategic-mou-to-establish-global-alliance-for-companion-diagnostic-cdx-kit-development
Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development
Published on 04/05/2018, 10:00 | 19279hits
the-swiss-biotech-association-honors-major-industry-achievements-with-swiss-biotech-success-stories
The Swiss Biotech Association Honors Major Industry Achievements with Swiss Biotech Success Stories
Published on 03/05/2018, 17:15 | 21520hits
haselmeier-and-common-sensing-enter-connected-injectable-medicine-collaboration
Haselmeier and Common Sensing Enter Connected Injectable Medicine Collaboration
Published on 03/05/2018, 09:00 | 31473hits
orchard-therapeutics-otl-200-receives-rare-pediatric-disease-designation-from-fda-for-treatment-of-metachromatic-leukodystrophy
Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of Metachromatic Leukodystrophy
Published on 01/05/2018, 13:30 | 34417hits
biogen-and-neurimmune-announce-option-exercise-for-alzheimer-s-disease-investigational-treatment-aducanumab
Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab
Published on 26/04/2018, 08:00 | 21716hits
neurimmune-appoints-fabian-buller-as-chief-business-officer
Neurimmune Appoints Fabian Buller as Chief Business Officer
Published on 24/04/2018, 14:00 | 21869hits
orchard-therapeutics-expands-us-presence-with-new-corporate-office-in-boston
Orchard Therapeutics Expands US Presence with New Corporate Office in Boston
Published on 24/04/2018, 12:30 | 21852hits
rapid-detection-of-pathogen-and-antibiotic-resistance-with-dnae-s-lidia-bloodstream-infection-bsi-technology
Rapid Detection of Pathogen and Antibiotic Resistance with DNAe’s LiDia® Bloodstream Infection (BSI) Technology
Published on 20/04/2018, 10:00 | 19844hits
sartorius-stedim-biotech-introduces-mini-microcarrier-bioreactor-for-culturing-adherent-cells
Sartorius Stedim Biotech Introduces Mini Microcarrier Bioreactor for Culturing Adherent Cells
Published on 18/04/2018, 10:00 | 22443hits
probiogen-signs-second-contract-development-agreement-with-tizona-therapeutics-for-immuno-oncology-antibody-project
ProBioGen Signs Second Contract Development Agreement with Tizona Therapeutics for Immuno-Oncology Antibody Project
Published on 17/04/2018, 16:45 | 22409hits
vetter-welcomes-illinois-governor-bruce-rauner-to-its-german-facilities
Vetter Welcomes Illinois Governor Bruce Rauner to its German Facilities
Published on 17/04/2018, 14:30 | 22442hits
wacker-strengthens-its-pharmaceutical-protein-business-and-buys-dutch-biotechnology-plant
WACKER Strengthens Its Pharmaceutical-Protein Business and Buys Dutch Biotechnology Plant
Published on 16/04/2018, 14:30 | 23846hits
sartorius-stedim-biotech-and-penn-state-university-announce-partnership
Sartorius Stedim Biotech and Penn State University Announce Partnership
Published on 13/04/2018, 15:00 | 22468hits
oncology-company-hercules-pharmaceuticals-to-present-ahr-inhibitor-efficacy-results-at-upcoming-aacr-meeting-on-monday-april-16
Oncology Company Hercules Pharmaceuticals to Present AhR Inhibitor Efficacy Results at Upcoming AACR Meeting on Monday April 16
Published on 13/04/2018, 14:00 | 22518hits
dnae-to-present-new-data-and-preview-its-blood-to-result-test-for-bloodstream-infection-at-eccmid-2018
DNAe to Present New Data and Preview its Blood-to-Result Test for Bloodstream Infection at ECCMID 2018
Published on 12/04/2018, 10:00 | 22182hits
potential-of-icosabutate-as-a-novel-approach-to-the-treatment-of-nash-highlighted-in-late-breaker-at-the-international-liver-congress-2018
Potential of Icosabutate as a Novel Approach to the Treatment of NASH Highlighted in Late-Breaker At The International Liver Congress™ 2018
Published on 12/04/2018, 09:00 | 20386hits
gsk-signs-strategic-agreement-to-transfer-rare-disease-gene-therapy-portfolio-to-orchard-therapeutics
GSK Signs Strategic Agreement to Transfer Rare Disease Gene Therapy Portfolio to Orchard Therapeutics
Published on 11/04/2018, 15:00 | 21405hits
aurigene-to-present-multiple-programs-at-the-aacr-2018-in-chicago-illinois-a-novel-small-molecule-oral-antagonists-of-cd47-sirp-interaction-b-novel-prmt5-inhibitors-c-covalent-selective-cdk12-inhibitors-and-d-smarca2-4-degraders
Aurigene to Present Multiple Programs at the AACR 2018 In Chicago, Illinois: (A) Novel Small Molecule, Oral, Antagonists of CD47-SIRPα Interaction; (B) Novel PRMT5 Inhibitors; (C) Covalent, Selective CDK12 Inhibitors and (D) SMARCA2/4 Degraders
Published on 11/04/2018, 09:00 | 20416hits
mimetas-secures-20-million-dollar-series-b-financing
MIMETAS Secures 20 Million Dollar Series B Financing
Published on 06/04/2018, 13:00 | 22627hits
selvita-to-present-new-data-from-its-oncology-programs-at-the-upcoming-aacr-annual-meeting-2018
Selvita to Present New Data from Its Oncology Programs at the Upcoming AACR Annual Meeting 2018
Published on 04/04/2018, 14:00 | 22761hits
tfs-international-to-strengthen-strategic-planning-capabilities-with-citeline-deal
TFS International to Strengthen Strategic Planning Capabilities with Citeline Deal
Published on 03/04/2018, 10:00 | 22647hits
tfs-international-appoints-dr-andrew-copestake-as-chief-commercial-officer
TFS International Appoints Dr Andrew Copestake as Chief Commercial Officer
Published on 23/03/2018, 09:15 | 22548hits
new-real-world-clinical-practice-data-reinforces-the-value-of-the-oncotype-dx-breast-recurrence-score-test-for-patients-physicians-and-the-health-care-system
New Real-World Clinical Practice Data Reinforces the Value of the Oncotype DX Breast Recurrence Score® Test for Patients, Physicians and the Health Care System
Published on 23/03/2018, 09:00 | 21269hits
medtech-company-ime-technologies-moves-to-new-and-much-larger-r-d-and-production-facility-in-waalre-the-netherlands
Medtech Company IME Technologies Moves to New and Much Larger R & D And Production Facility in Waalre, The Netherlands
Published on 21/03/2018, 15:35 | 20895hits
vetter-wins-2018-ipse-facility-of-the-year-award
Vetter Wins 2018 ISPE Facility of the Year Award
Published on 21/03/2018, 09:00 | 22880hits
agendia-announces-ce-mark-for-ngs-based-mammaprint-blueprint-kit-enhancing-access-to-personalized-treatment-for-breast-cancer-patients-in-europe
Agendia Announces CE Mark for NGS-Based MammaPrint® BluePrint® Kit Enhancing Access to Personalized Treatment for Breast Cancer Patients in Europe
Published on 21/03/2018, 09:00 | 22775hits
orchard-therapeutics-strengthens-executive-leadership-team-with-appointment-of-chief-commercial-officer-and-general-counsel
Orchard Therapeutics Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer and General Counsel
Published on 16/03/2018, 14:45 | 23929hits
sartorius-stedim-biotech-supports-abl-europe-in-successful-completion-of-viral-vector-gmp-capacity-expansion
Sartorius Stedim Biotech Supports ABL Europe in Successful Completion of Viral Vector GMP Capacity Expansion
Published on 14/03/2018, 16:00 | 24159hits
sartorius-stedim-biotech-launches-new-ambr-250-high-throughput-bioreactor-system-for-perfusion-culture
Sartorius Stedim Biotech Launches New ambr® 250 High Throughput Bioreactor System for Perfusion Culture
Published on 09/03/2018, 09:00 | 20695hits
orchard-therapeutics-scientific-founder-prof-donald-kohn-recognized-with-pediatric-blood-and-marrow-transplant-consortium-lifetime-achievement-award
Orchard Therapeutics Scientific Founder Prof Donald Kohn Recognized with Pediatric Blood and Marrow Transplant Consortium Lifetime Achievement Award
Published on 08/03/2018, 10:00 | 23792hits
probiogen-and-surface-oncology-sign-second-antibody-manufacturing-program
ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program
Published on 06/03/2018, 16:30 | 23963hits
orchard-therapeutics-to-present-at-the-cowen-and-company-annual-healthcare-conference
Orchard Therapeutics to Present at the Cowen and Company Annual Healthcare Conference
Published on 02/03/2018, 15:00 | 24962hits
judith-heikoop-appointed-managing-director-at-biomedical-electro-spinning-company-ime-technologies
Judith Heikoop Appointed Managing Director at Biomedical Electro Spinning Company IME Technologies
Published on 28/02/2018, 14:30 | 23584hits
project-pharmaceutics-expands-facilities-for-formulation-and-lyophilization-process-development-to-meet-safety-requirements-for-gmo-s2-and-bsl-2-biological-products
ProJect Pharmaceutics Expands Facilities for Formulation and Lyophilization Process Development to Meet Safety Requirements for GMO S2 and BSL-2 Biological Products
Published on 27/02/2018, 16:00 | 24005hits
biopharmaspec-launches-new-host-cell-protein-detection-service
BioPharmaSpec Launches New Host Cell Protein Detection Service
Published on 21/02/2018, 09:30 | 25452hits
serious-about-serialisation-dcc-vital-selects-rfxcel-for-eu-fmd-compliance
Serious About Serialisation: DCC Vital Selects rfxcel for EU FMD Compliance
Published on 16/02/2018, 14:15 | 25809hits
selvita-announces-successful-completion-of-41-m-book-building
Selvita Announces Successful Completion of $41 M Book Building
Published on 15/02/2018, 15:30 | 24325hits
vetter-is-a-winner-of-the-fraunhofer-clean-manufacturing-award-clean-2018
Vetter Is a Winner of the Fraunhofer Clean Manufacturing Award CLEAN! 2018
Published on 13/02/2018, 14:45 | 21837hits
orchard-therapeutics-to-present-at-the-rbc-capital-markets-2018-global-healthcare-conference
Orchard Therapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference
Published on 13/02/2018, 14:30 | 24450hits
new-isolute-hydro-dme-rapidly-removes-matrix-interferences-from-urine
New ISOLUTE® HYDRO DME+ Rapidly Removes Matrix Interferences from Urine
Published on 07/02/2018, 10:00 | 23056hits
probiogen-and-teva-sign-license-agreement-on-human-artificial-lymph-node-technology
ProBioGen and TEVA Sign License Agreement on Human Artificial Lymph Node Technology
Published on 06/02/2018, 09:00 | 25329hits
selvita-appoints-steffen-heeger-m-d-phd-as-chief-medical-officer
Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer
Published on 05/02/2018, 09:00 | 25034hits
orchard-therapeutics-appoints-dr-harry-malech-to-scientific-advisory-board
Orchard Therapeutics Appoints Dr. Harry Malech to Scientific Advisory Board
Published on 02/02/2018, 15:00 | 25146hits
vetter-introduces-south-korea-s-pharma-and-biotech-community-to-meet-company-management
Vetter Introduces South Korea’s Pharma and Biotech Community to Meet Company Management
Published on 29/01/2018, 09:00 | 28341hits
zz-biotech-announces-preliminary-phase-2-stroke-trial-results-with-3k3a-apc
ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC
Published on 25/01/2018, 14:00 | 26101hits
araclon-biotech-partners-with-tfs-international-for-their-alzheimer-s-phase-ii-trial
Araclon Biotech Partners with TFS International for Their Alzheimer’s Phase II Trial
Published on 17/01/2018, 17:05 | 25864hits
futuragene-s-exclusive-license-for-rnai-technology-in-eucalyptus-enhanced-by-grant-of-patent-in-brazil
FuturaGene's Exclusive License for RNAi Technology in Eucalyptus Enhanced by Grant of Patent in Brazil
Published on 17/01/2018, 09:00 | 26645hits
orchard-therapeutics-appoints-frank-thomas-as-chief-financial-officer-and-chief-business-officer
Orchard Therapeutics Appoints Frank Thomas as Chief Financial Officer and Chief Business Officer
Published on 16/01/2018, 10:30 | 25541hits
batavia-biosciences-teams-up-with-international-consortium-to-support-polio-eradication
Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication
Published on 15/01/2018, 15:00 | 26431hits
biontech-announces-results-from-two-more-studies-demonstrating-the-benefits-of-breast-cancer-subtyping-using-mammatyper
BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper®
Published on 10/01/2018, 14:05 | 24001hits
tfs-international-appoints-new-chief-executive-officer
TFS International Appoints New Chief Executive Officer
Published on 09/01/2018, 10:05 | 27279hits
wacker-obtains-fda-approval-to-manufacture-the-drug-substance-in-retavase-a-thrombolysis-medication-by-chiesi
WACKER Obtains FDA Approval to Manufacture the Drug Substance in Retavase®, a Thrombolysis Medication by Chiesi
Published on 05/01/2018, 13:00 | 25632hits
antabio-announces-key-executive-appointments
ANTABIO Announces Key Executive Appointments
Published on 04/01/2018, 08:00 | 27151hits
abzena-selects-sartorius-stedim-biotech-to-equip-its-us-based-development-and-manufacturing-sites-in-san-diego-and-bristol
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites in San Diego and Bristol
Published on 22/12/2017, 10:00 | 29642hits
orchard-therapeutics-to-present-at-the-36th-annual-j-p-morgan-healthcare-conference
Orchard Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
Published on 21/12/2017, 14:30 | 29536hits
rfxcel-approved-as-a-technically-certified-connection-provider-for-emvo
rfxcel Approved as a Technically Certified Connection Provider for EMVO
Published on 20/12/2017, 09:00 | 32851hits
orchard-therapeutics-announces-110m-series-b-financing-to-advance-transformative-gene-therapy-pipeline
Orchard Therapeutics Announces $110M Series B Financing to Advance Transformative Gene Therapy Pipeline
Published on 19/12/2017, 15:00 | 30173hits
agendia-and-bluebee-partner-to-bring-new-ngs-based-mammaprint-blueprint-breast-cancer-kit-to-market
Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint® BluePrint® Breast Cancer Kit to Market
Published on 15/12/2017, 12:00 | 28733hits
orchard-therapeutics-and-genethon-announce-gene-therapy-alliance-in-x-linked-chronic-granulomatous-disease
Orchard Therapeutics and Généthon Announce Gene Therapy Alliance in X-linked Chronic Granulomatous Disease
Published on 14/12/2017, 11:00 | 28888hits
fda-grants-orphan-drug-designation-to-zytoprotec-s-novel-dialysis-fluid
FDA Grants Orphan Drug Designation to Zytoprotec's Novel Dialysis Fluid
Published on 14/12/2017, 09:00 | 30859hits
thrombolytic-science-announces-the-appointment-of-annalisa-jenkins-mbbs-frcp-as-a-non-executive-board-member
Thrombolytic Science Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as a Non-Executive Board Member
Published on 13/12/2017, 11:00 | 30442hits
key-executives-join-the-rfxcel-team-to-drive-global-growth
Key Executives Join the rfxcel Team to Drive Global Growth
Published on 12/12/2017, 15:00 | 46457hits
agendia-key-studies-presented-at-the-san-antonio-breast-cancer-symposium-demonstrate-the-important-role-of-mammaprint-for-patient-pre-selection-cost-effectiveness-and-for-younger-patients
Agendia: Key Studies Presented at the San Antonio Breast Cancer Symposium Demonstrate the Important Role of MammaPrint® for Patient Pre-Selection, Cost-Effectiveness and For Younger Patients
Published on 12/12/2017, 14:00 | 27018hits
dr-hitto-kaufmann-of-sanofi-aventis-and-dr-eliana-clark-of-biogen-to-deliver-plenary-keynote-presentations-at-chi-s-bioprocessing-summit-europe
Dr. Hitto Kaufmann of Sanofi-Aventis and Dr. Eliana Clark of Biogen to Deliver Plenary Keynote Presentations at CHI’s Bioprocessing Summit Europe
Published on 12/12/2017, 10:10 | 31105hits
biogenes-establishes-scientific-advisory-board
BioGenes Establishes Scientific Advisory Board
Published on 12/12/2017, 10:00 | 31605hits
northsea-therapeutics-secures-25-million-funding-for-clinical-development-of-promising-nash-drug
NorthSea Therapeutics Secures €25 Million Funding for Clinical Development of Promising NASH Drug
Published on 11/12/2017, 09:00 | 25764hits
genomic-health-new-validation-shows-oncotype-dx-breast-recurrence-score-test-predicts-clinical-response-to-neoadjuvant-hormonal-therapy-to-improve-surgical-outcomes-in-certain-patients-with-large-tumors
Genomic Health: New Validation Shows Oncotype DX Breast Recurrence Score® Test Predicts Clinical Response to Neoadjuvant Hormonal Therapy to Improve Surgical Outcomes in Certain Patients with Large Tumors
Published on 07/12/2017, 14:00 | 26560hits
sartorius-stedim-biotech-launches-new-versions-of-data-analytics-software-solutions
Sartorius Stedim Biotech Launches New Versions of Data Analytics Software Solutions
Published on 07/12/2017, 09:00 | 38095hits
agendia-and-uz-leuven-partner-to-co-validate-mammaprint-blueprint-breast-cancer-risk-of-recurrence-and-molecular-subtyping-kit-ahead-of-european-launch
Agendia and UZ Leuven Partner to Co-Validate MammaPrint® BluePrint® Breast Cancer Risk of Recurrence and Molecular Subtyping Kit Ahead of European Launch
Published on 06/12/2017, 15:30 | 27812hits
vetter-receives-corporate-health-award-s-recognition-of-excellence
Vetter Receives Corporate Health Award’s Recognition of Excellence
Published on 05/12/2017, 09:00 | 30393hits
agendia-collaborates-with-prestigious-cancer-center-institut-curie-for-mammaprint-blueprint-breast-cancer-kit-co-validation-study
Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint® BluePrint® Breast Cancer Kit Co-Validation Study
Published on 01/12/2017, 09:00 | 25585hits
polyganics-awarded-1-2-million-to-complete-clinical-development-of-dura-sealant-patch
Polyganics Awarded €1.2 Million to Complete Clinical Development of Dura Sealant Patch
Published on 30/11/2017, 15:00 | 24521hits
new-data-at-the-san-antonio-breast-cancer-symposium-demonstrate-the-value-of-mammaprint-and-blueprint-across-breast-cancer-patient-populations
New Data at the San Antonio Breast Cancer Symposium Demonstrate the Value of MammaPrint® and BluePrint® Across Breast Cancer Patient Populations
Published on 30/11/2017, 14:00 | 25389hits
selvita-promotes-edyta-jaworska-to-the-management-board-to-strengthen-development-in-integrated-drug-discovery-services
Selvita Promotes Edyta Jaworska to the Management Board to Strengthen Development in Integrated Drug Discovery Services
Published on 30/11/2017, 09:00 | 27544hits
orchard-therapeutics-announces-expansion-of-technical-operations-in-california
Orchard Therapeutics Announces Expansion of Technical Operations in California
Published on 29/11/2017, 14:00 | 28434hits
second-sartorius-research-xchange-forum-focuses-on-regenerative-medicine-and-cell-therapy
Second Sartorius Research Xchange Forum Focuses On Regenerative Medicine and Cell Therapy
Published on 28/11/2017, 15:00 | 26978hits
agendia-s-mammaprint-breast-cancer-risk-of-recurrence-test-obtains-favorable-final-payment-determination-from-cms-for-new-unique-category-1-cpt-code
Agendia’s MammaPrint® Breast Cancer Risk-of-Recurrence Test Obtains Favorable Final Payment Determination from CMS for New, Unique Category 1 CPT Code
Published on 28/11/2017, 11:05 | 25320hits
sotio-broadens-its-phase-ii-clinical-trial-program-in-ovarian-cancer
SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer
Published on 28/11/2017, 11:00 | 28034hits
nbe-therapeutics-appoints-dr-nicole-onetto-to-its-board-of-directors
NBE-Therapeutics Appoints Dr. Nicole Onetto to Its Board of Directors
Published on 28/11/2017, 09:00 | 27766hits
cristal-therapeutics-awarded-2-5-million-horizon-2020-grant-to-advance-its-cripec-docetaxel-through-phase-2-trials
Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials
Published on 27/11/2017, 09:00 | 27863hits
orchard-therapeutics-announces-extension-of-its-collaboration-with-manchester-university-to-include-sanfilippo-syndrome-type-b
Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B
Published on 21/11/2017, 12:30 | 29786hits
lead-pharma-achieves-third-milestone-in-sanofi-collaboration-for-development-of-autoimmune-diseases-treatments
Lead Pharma Achieves Third Milestone in Sanofi Collaboration for Development of Autoimmune Diseases Treatments
Published on 20/11/2017, 15:00 | 29019hits
ajcc-confirms-mammaprints-clinical-utility-for-treatment-decisions-and-staging-in-recent-8th-edition-breast-chapter-update
AJCC Confirms MammaPrint's Clinical Utility for Treatment Decisions and Staging in Recent 8th Edition Breast Chapter Update
Published on 20/11/2017, 10:00 | 28170hits
leon-nanodrugs-congratulates-its-partner-mjr-pharmjet-on-receiving-prestigious-cphi-award-2017-for-highly-innovative-microjet-reactor-technology
leon-nanodrugs Congratulates its Partner MJR Pharmjet on Receiving Prestigious CPhI Award 2017 for Highly Innovative MicroJet Reactor Technology
Published on 17/11/2017, 15:30 | 30332hits
successful-first-in-human-testing-of-implandatas-next-generation-eyemate-micro-sensor-for-improved-monitoring-of-glaucoma-patients
Successful First-in-Human Testing of Implandata’s Next Generation EYEMATE™ Micro-Sensor for Improved Monitoring of Glaucoma Patients
Published on 09/11/2017, 15:40 | 29053hits
vetter-expands-its-footprint-in-asia-pacific-region
Vetter Expands its Footprint in Asia Pacific Region
Published on 09/11/2017, 14:15 | 57643hits
redhill-biopharma-announces-last-patient-enrolled-in-the-phase-iii-study-with-rhb-104-for-crohns-disease
RedHill Biopharma Announces Last Patient Enrolled in the Phase III Study with RHB-104 for Crohn's Disease
Published on 09/11/2017, 10:00 | 30503hits
apceth-biopharma-appoints-a-new-supervisory-board
apceth Biopharma Appoints a New Supervisory Board
Published on 09/11/2017, 09:15 | 29129hits
neogenomics-europe-sa-opens-its-doors-in-rolle-switzerland-laboratory-hosting-business-leaders-dignitaries-and-local-government-officials
NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials
Published on 06/11/2017, 11:00 | 30920hits
sotio-completes-enrolment-of-phase-iii-viable-study-in-late-stage-prostate-cancer
SOTIO Completes Enrolment of Phase III VIABLE Study in Late Stage Prostate Cancer
Published on 03/11/2017, 08:00 | 32029hits
celonic-acquires-glycotopes-bio-manufacturing-facility
Celonic Acquires Glycotope’s Bio-manufacturing Facility
Published on 01/11/2017, 13:45 | 30191hits
redhill-biopharma-and-intelgenx-submit-new-drug-application-to-fda-for-rizaportr-for-migraines
RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines
Published on 01/11/2017, 09:00 | 28112hits
cristal-therapeutics-progresses-nanomedicine-cripecr-docetaxel-to-phase-1b-development-in-patients-with-solid-tumours
Cristal Therapeutics Progresses Nanomedicine CriPec®-docetaxel to Phase 1b Development in Patients with Solid Tumours
Published on 31/10/2017, 13:45 | 28401hits
biogeneration-ventures-fund-iii-reaches-eur-82-million-in-final-close
BioGeneration Ventures Fund III Reaches EUR 82 Million in Final Close
Published on 24/10/2017, 17:00 | 31719hits
sartorius-stedim-biotech-wins-frost-a-sullivan-award-for-customer-service-leadership-in-bioanalytical-contract-testing
Sartorius Stedim Biotech Wins Frost & Sullivan Award for Customer Service Leadership in Bioanalytical Contract Testing
Published on 24/10/2017, 15:00 | 27984hits
neogenomics-announces-the-opening-of-its-first-international-laboratory-near-geneva-switzerland-to-support-clinical-trials
NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials
Published on 24/10/2017, 09:00 | 29688hits
corflow-completes-the-first-close-of-the-seed-financing-round
CorFlow Completes the First Close of the Seed+ Financing Round
Published on 19/10/2017, 16:00 | 27576hits
vetter-to-expand-its-secondary-packaging-service-capacity-to-meet-rising-demands
Vetter To Expand its Secondary Packaging Service Capacity to Meet Rising Demands
Published on 19/10/2017, 10:00 | 30986hits
dcprime-and-apceth-biopharma-gmbh-announce-manufacturing-partnership
DCPrime and apceth Biopharma GmbH Announce Manufacturing Partnership
Published on 17/10/2017, 10:00 | 30985hits
The Netherlands Cancer Institute Awarded Funding to Apply Molecular Imaging Technology to Prostate Cancer Surgery
Published on 16/10/2017, 10:00 | 30417hits
batavia-biosciences-expands-its-viral-vector-and-gmp-facilities-to-accommodate-increasing-market-demand
Batavia Biosciences Expands its Viral Vector and GMP Facilities to Accommodate Increasing Market Demand
Published on 16/10/2017, 09:00 | 31933hits
antabio-raises-73m-series-a-financing-to-develop-novel-treatments-against-drug-resistant-gram-negative-infections
ANTABIO Raises € 7.3M Series A Financing to Develop Novel Treatments against Drug-Resistant Gram-Negative Infections
Published on 11/10/2017, 15:30 | 28523hits
mc2-therapeutics-as-announces-first-patient-dosed-in-pivotal-us-phase-3-trial-in-psoriasis-vulgaris
MC2 Therapeutics A/S Announces First Patient Dosed in Pivotal US Phase 3 Trial in Psoriasis Vulgaris
Published on 10/10/2017, 11:00 | 30638hits
ce-marking-for-worlds-only-integrated-hiv-self-test-from-atomo-diagnostics-gives-access-to-safe-accurate-and-reliable-self-testing
CE Marking for World’s Only Integrated HIV Self-Test from Atomo Diagnostics Gives Access to Safe, Accurate and Reliable Self-Testing
Published on 09/10/2017, 14:00 | 31050hits
oncoarendi-therapeutics-to-begin-the-phase-1-clinical-evaluation-of-its-novel-class-of-medicines
OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines
Published on 05/10/2017, 10:15 | 31276hits
regulatory-approval-in-europe-granted-for-synthons-glatiramer-acetate-40-mgml
Regulatory Approval in Europe Granted for Synthon's Glatiramer Acetate 40 mg/ml
Published on 05/10/2017, 10:00 | 28655hits
chiome-bioscience-selects-probiogen-for-glymaxxr-antibody-manufacturing-program
Chiome Bioscience Selects ProBioGen for GlymaxX® Antibody Manufacturing Program
Published on 04/10/2017, 13:00 | 28025hits
rentschler-biotechnologie-gmbh-announces-transition-into-a-european-corporation-called-rentschler-biopharma-se
Rentschler Biotechnologie GmbH Announces Transition into a European Corporation Called Rentschler Biopharma SE
Published on 04/10/2017, 09:00 | 31144hits
immatics-receives-usd-58-million-in-financing-to-develop-t-cell-receptor-based-immunotherapies
Immatics Receives USD 58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies
Published on 03/10/2017, 14:20 | 36389hits
redhill-biopharma-announces-positive-top-line-results-from-phase-ii-study-of-bekindar-in-patients-with-diarrhea-predominant-irritable-bowel-syndrome-ibs-d
RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Published on 02/10/2017, 16:00 | 27653hits
dutch-mellon-medical-secures-6-million-for-market-introduction-of-major-innovation-in-surgical-suture-technology-single-handed-suturing-using-the-switchr
Dutch Mellon Medical Secures € 6 Million for Market Introduction of Major Innovation in Surgical Suture Technology: Single-Handed Suturing Using the Switch®
Published on 02/10/2017, 15:00 | 29612hits
PnuVax Awarded USD29.4 Million USD Grant to Advance Innovative Vaccine into Clinical Trials
Published on 02/10/2017, 13:45 | 30125hits
redhill-biopharma-accelerates-rhb-104-phase-iii-study-in-crohns-disease-with-top-line-results-expected-mid-2018
RedHill Biopharma Accelerates RHB-104 Phase III Study in Crohn’s Disease with Top-Line Results Expected Mid-2018
Published on 28/09/2017, 14:50 | 29899hits
vetter-lays-the-foundation-for-a-state-of-the-art-administration-building
Vetter Lays the Foundation for a State-of-the-Art Administration Building
Published on 27/09/2017, 15:30 | 31002hits
swiss-biotech-association-strengthens-its-board-of-directors-and-appoints-michael-altorfer-as-its-new-ceo
Swiss Biotech Association Strengthens Its Board of Directors and Appoints Michael Altorfer As Its New CEO
Published on 27/09/2017, 10:00 | 29493hits
rfxcel-drives-eu-expansion-with-industry-experts
rfxcel Drives EU Expansion with Industry Experts
Published on 21/09/2017, 09:00 | 31095hits
oncoqr-mls-vaccine-platform-closes-the-final-gap-in-the-immunological-attack-against-cancer
OncoQR ML's Vaccine Platform Closes the Final Gap in the Immunological Attack Against Cancer
Published on 20/09/2017, 10:00 | 30800hits
sgi-dna-and-biocat-announce-distribution-partnership-for-vmax-express-protein-expression-platform
SGI-DNA and BioCat Announce Distribution Partnership for Vmax™ Express Protein Expression Platform
Published on 19/09/2017, 12:00 | 28348hits
molecular-devices-and-cytena-partner-to-launch-the-cloneselect-single-cell-printer
Molecular Devices and Cytena Partner to Launch the CloneSelect Single-Cell Printer
Published on 19/09/2017, 09:30 | 29046hits
aplagon-partners-with-cadila-pharmaceuticals-to-develop-and-commercialize-apac-first-in-class-antithrombotics-for-the-prevention-of-blood-vessel-occlusions-related-to-vascular-interventions
Aplagon Partners with Cadila Pharmaceuticals to Develop and Commercialize APAC First-in-Class Antithrombotics for the Prevention of Blood Vessel Occlusions Related to Vascular Interventions
Published on 18/09/2017, 11:15 | 29160hits
varmx-announces-publication-in-nature-communications-of-groundbreaking-snake-venom-inspired-approach-to-restore-blood-clotting-in-patients-using-anticoagulants
VarmX Announces Publication in Nature Communications of Groundbreaking Snake Venom Inspired Approach to Restore Blood Clotting in Patients Using Anticoagulants
Published on 18/09/2017, 10:15 | 29708hits
new-in-situ-hydrolysis-spe-plates-from-biotage
New In-situ Hydrolysis SPE Plates from Biotage
Published on 18/09/2017, 10:00 | 29576hits
shuwen-biotech-receives-ce-mark-for-egfr-mutation-pcr-kit-for-lung-cancer
Shuwen Biotech Receives CE Mark for EGFR Mutation PCR Kit for Lung Cancer
Published on 14/09/2017, 10:00 | 31187hits
levicept-starts-first-in-human-phase-i-trial-of-levi-04-a-novel-fusion-protein-therapy-for-chronic-pain
Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel Fusion Protein Therapy for Chronic Pain
Published on 13/09/2017, 15:30 | 33891hits
der-sartorius-campus-waechst-einweihung-des-neuen-produktionsgebaeudes-fuer-laborinstrumente
Der Sartorius Campus wächst: Einweihung des neuen Produktionsgebäudes für Laborinstrumente
Published on 13/09/2017, 14:45 | 66530hits
redhill-biopharma-initiates-promotion-of-esomeprazole-strontium-delayed-release-capsules-493-mg-in-the-us
RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.
Published on 13/09/2017, 13:15 | 29274hits
european-patent-office-decides-in-synthons-favor-in-glatiramer-patent-case
European Patent Office Decides in Synthon's Favor in Glatiramer Patent Case
Published on 12/09/2017, 13:00 | 29849hits
invicro-acquires-imanova-to-expand-global-imaging-capabilities
Invicro Acquires Imanova to Expand Global Imaging Capabilities
Published on 12/09/2017, 11:00 | 28933hits
successful-industrial-gmp-manufacturing-of-riboxxim-a-novel-and-highly-potent-toll-like-3-ligand-for-immunotherapy-of-cancer
Successful Industrial GMP Manufacturing of RIBOXXIM, a Novel and Highly Potent Toll-like 3 Ligand for Immunotherapy of Cancer
Published on 11/09/2017, 08:00 | 27850hits
new-analysis-from-german-study-group-prospective-trial-shows-minimal-distant-recurrence-in-patients-with-clinically-high-risk-breast-cancer-and-low-oncotype-dx-breast-recurrence-scorer-results
New Analysis from German Study Group Prospective Trial Shows Minimal Distant Recurrence in Patients with Clinically High-Risk Breast Cancer and Low Oncotype DX Breast Recurrence Score® Results Following Five Years of Hormone Therapy Alone
Published on 08/09/2017, 12:00 | 27461hits
robust-performance-of-oncobeam-ras-crc-liquid-biopsy-testing-in-routine-clinical-practice-for-colorectal-cancer-patients-highlighted-at-esmo-2017
Robust Performance of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients Highlighted at ESMO 2017
Published on 06/09/2017, 10:00 | 23780hits
congenicas-sapientia-selected-by-coimbra-paediatric-hospital-for-portugals-in2genome-genetic-disease-diagnosis-project
Congenica’s Sapientia™ Selected by Coimbra Paediatric Hospital for Portugal’s In2Genome Genetic Disease Diagnosis Project
Published on 05/09/2017, 10:00 | 24192hits
amal-therapeutics-raises-eur-8-million-chf-8-8-million-in-first-closing-of-series-b-financing-round
AMAL Therapeutics Raises EUR 8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round
Published on 01/09/2017, 14:45 | 23480hits
asian-study-of-over-15000-mammograms-underlines-the-potential-value-of-sigmascreenings-sensitive-sigma-paddle-solution-for-pressure-guided-mammography
Asian Study of Over 15,000 Mammograms Underlines the Potential Value of Sigmascreening’s Sensitive Sigma™ Paddle Solution for Pressure Guided Mammography
Published on 22/08/2017, 10:00 | 27163hits
orchard-therapeutics-announces-that-otl-101-has-received-a-designation-as-promising-innovative-medicine-by-uks-regulatory-agency
Orchard Therapeutics Announces That OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency
Published on 21/08/2017, 09:00 | 28459hits
immatics-initiates-personalized-adoptive-cellular-therapy-in-patients-with-relapsed-andor-refractory-solid-cancers-using-its-pioneering-target-warehouse
Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse
Published on 17/08/2017, 14:00 | 50180hits
redhill-biopharma-announces-us-commercialization-agreement-for-fda-approved-gi-product-esomeprazole-strontium-delayed-release-capsules
RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules
Published on 16/08/2017, 08:50 | 30342hits
mimetas-develops-high-throughput-gut-on-a-chip-technology-in-collaboration-with-pharmaceutical-company
MIMETAS Develops High-Throughput Gut-on-a-chip Technology in Collaboration with Pharmaceutical Company
Published on 10/08/2017, 15:15 | 69371hits
redhill-biopharma-provides-2017-semi-annual-business-update
RedHill Biopharma Provides 2017 Semi-Annual Business Update
Published on 10/08/2017, 10:00 | 31510hits
orchard-therapeutics-appoints-mark-rothera-as-ceo
Orchard Therapeutics Appoints Mark Rothera as CEO
Published on 31/07/2017, 15:00 | 37256hits
redhill-biopharma-announces-unanimous-positive-dsmb-recommendation-for-continuation-of-the-phase-iii-study-with-rhb-104-for-crohns-disease
RedHill Biopharma Announces Unanimous Positive DSMB Recommendation for Continuation of the Phase III Study with RHB-104 for Crohn's Disease
Published on 31/07/2017, 10:00 | 35145hits
bioscience-managers-appoints-elizabeth-klein-as-investment-consultant-in-the-uk-to-support-bioscience-managers-and-downings-life-sciences-investments
BioScience Managers Appoints Elizabeth Klein as Investment Consultant in the UK to Support BioScience Managers' and Downing's Life Sciences Investments
Published on 25/07/2017, 14:00 | 32433hits
biogenes-celebrates-25-years-of-excellence-in-quality-control-of-biotherapeutics
BioGenes Celebrates 25 Years of Excellence in Quality Control of Biotherapeutics
Published on 25/07/2017, 10:30 | 32550hits
unicyte-ag-regenerative-medicine-unit-of-fresenius-medical-care-appoints-world-leading-experts-to-scientific-advisory-board
Unicyte AG, Regenerative Medicine Unit of Fresenius Medical Care, Appoints World-Leading Experts to Scientific Advisory Board
Published on 25/07/2017, 08:30 | 30367hits
antabio-awarded-up-to-89m-from-carb-x-to-accelerate-the-development-of-its-new-treatment-for-chronic-infections-in-cystic-fibrosis-patients
ANTABIO Awarded Up to USD8.9M from CARB-X to Accelerate the Development of Its New Treatment For Chronic Infections in Cystic Fibrosis Patients
Published on 24/07/2017, 10:00 | 32717hits
orchard-therapeutics-announces-that-otl-101-has-received-a-rare-paediatric-disease-designation
Orchard Therapeutics Announces That OTL-101 Has Received a Rare Paediatric Disease Designation
Published on 17/07/2017, 15:45 | 68303hits
redhill-biopharma-announces-last-patient-visit-in-bekindar-phase-ii-study-for-ibs-d
RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D
Published on 17/07/2017, 09:00 | 27788hits
new-study-presented-at-alzheimers-association-international-conference-2017-aaic-validates-equivalency-of-pen-and-paper-cognitive-assessment-sage-with-its-digital-counterpart-esage-to-detect-mild-cognitive-impairment-and-early-dementias
New Study Presented at Alzheimer’s Association International Conference 2017 (AAIC) Validates Equivalency of Pen-and-Paper Cognitive Assessment (SAGE) with its Digital Counterpart (eSAGE) to Detect Mild Cognitive Impairment and Early Dementias
Published on 12/07/2017, 14:45 | 28221hits
redhill-biopharma-announces-expected-timeline-for-dsmb-meeting-and-provides-update-on-enrollment-in-the-rhb-104-phase-iii-study-for-crohns-disease
RedHill Biopharma Announces Expected Timeline for DSMB Meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease
Published on 12/07/2017, 10:00 | 31020hits
genomic-health-updated-st-gallen-international-breast-cancer-guidelines-reinforce-important-role-of-genomic-testing-in-treatment-of-early-breast-cancer
Genomic Health: Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role of Genomic Testing in Treatment of Early Breast Cancer
Published on 11/07/2017, 14:00 | 31467hits
daiichi-sankyo-max-planck-innovation-and-lead-discovery-center-announce-cancer-research-collaboration
Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Announce Cancer Research Collaboration
Published on 10/07/2017, 22:25 | 31186hits
agendias-mammaprintr-recommended-by-asco-breast-cancer-guideline-in-focused-update-based-on-landmark-mindact-trial-data
Agendia’s MammaPrint® Recommended by ASCO Breast Cancer Guideline in Focused Update Based on Landmark MINDACT Trial Data
Published on 05/07/2017, 11:00 | 29397hits
nature-publication-for-cellmids-midkine-in-cancer
Nature Publication for Cellmid’s Midkine in Cancer
Published on 29/06/2017, 13:45 | 32362hits
new-second-generation-solvent-evaporators-from-biotage
New Second Generation Solvent Evaporators from Biotage
Published on 28/06/2017, 13:00 | 110260hits
merlion-and-dstl-awarded-dtra-grant-to-explore-the-use-of-finafloxacin-against-biological-threat-agents
MerLion and Dstl Awarded DTRA Grant to Explore the Use of Finafloxacin against Biological Threat Agents
Published on 27/06/2017, 10:30 | 32650hits
sartorius-and-science-magazine-to-award-prize-for-regenerative-medicine-and-cell-therapy
Sartorius and Science Magazine to Award Prize for Regenerative Medicine and Cell Therapy
Published on 27/06/2017, 09:00 | 32493hits
biogeneration-ventures-fund-iii-secures-eur-66m-exceeding-eur-50m-target
BioGeneration Ventures Fund III Secures EUR 66m, Exceeding EUR 50m Target
Published on 26/06/2017, 14:00 | 31630hits
active-dashboard-2-allows-easy-access-to-process-performance-data
Active Dashboard 2 Allows Easy Access to Process Performance Data
Published on 23/06/2017, 12:30 | 32186hits
sartorius-stedim-biotech-introduces-sartobindr-cassettes
Sartorius Stedim Biotech Introduces Sartobind® Cassettes
Published on 21/06/2017, 08:00 | 29379hits
oncoarendi-therapeutics-announces-selection-of-its-second-clinical-development-candidate-oatd-02-for-the-treatment-of-multiple-cancers
OncoArendi Therapeutics Announces Selection of Its Second Clinical Development Candidate: OATD-02 For the Treatment of Multiple Cancers
Published on 15/06/2017, 16:15 | 113534hits
redhill-biopharma-announces-confirmatory-phase-iii-study-initiated-with-rhb-105-talicia-for-h-pylori-infection
RedHill Biopharma Announces Confirmatory Phase III Study Initiated with RHB-105 (TALICIA™) for H. pylori Infection
Published on 15/06/2017, 10:00 | 30366hits
probiogen-grants-a-license-for-human-lymph-node-technology-to-tissuse-for-multi-organ-chip-applications
ProBioGen Grants a License for Human Lymph Node Technology to TissUse for Multi-Organ-Chip Applications
Published on 14/06/2017, 15:00 | 99099hits
redhill-biopharma-announces-successful-phase-iii-top-line-results-with-bekindar-for-acute-gastroenteritis
RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis
Published on 13/06/2017, 16:30 | 87971hits
redhill-biopharma-initiates-promotion-of-donnatalr-and-enteragamr-in-the-us
RedHill Biopharma Initiates Promotion of Donnatal® and EnteraGam® in the U.S.
Published on 13/06/2017, 09:00 | 27326hits
rentschler-biotechnologie-and-rentschler-fill-solutions-announce-strategic-partnership-for-one-stop-solutions-with-new-state-of-the-art-fill-and-finish-facilities
Rentschler Biotechnologie and Rentschler Fill Solutions Announce Strategic Partnership for One-Stop Solutions with New State-Of-The-Art Fill and Finish Facilities
Published on 13/06/2017, 08:30 | 30732hits
centogene-raises-a-eur-25-million-series-a-financing-to-fuel-innovation-and-to-accelerate-growth-into-personalized-medicine
CENTOGENE Raises a EUR 25 Million Series A Financing to Fuel Innovation and to Accelerate Growth into Personalized Medicine
Published on 09/06/2017, 13:00 | 31444hits
zytoprotecs-novel-dialysis-product-meets-both-endpoints-in-phase-ii-study
Zytoprotec's Novel Dialysis Product Meets Both Endpoints in Phase II Study
Published on 06/06/2017, 11:00 | 31203hits
genomic-health-new-data-show-important-role-of-genomic-testing-in-treatment-of-older-breast-cancer-patients
Genomic Health: New Data Show Important Role of Genomic Testing in Treatment of Older Breast Cancer Patients
Published on 05/06/2017, 14:00 | 31218hits
sartorius-stedim-biotech-launches-ambrr-15-bioreactor-system-with-nova-bioprofiler-flex2-integration-
Sartorius Stedim Biotech Launches ambr® 15 Bioreactor System with Nova BioProfile® FLEX2 Integration
Published on 04/06/2017, 13:25 | 28152hits
f-star-expands-its-relationship-with-merck-through-a-new-strategic-collaboration-to-develop-bispecific-antibodies-in-immuno-oncology
F-star Expands its Relationship with Merck through a new Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology
Published on 02/06/2017, 14:00 | 30967hits
appointment-of-bent-johnsen-as-ceo-for-emperrar
Appointment of Bent Johnsen as CEO for EMPERRA®
Published on 31/05/2017, 15:00 | 47696hits
vetter-and-microdermics-enter-into-a-strategic-cooperation-agreement-to-develop-innovative-microneedle-drug-delivery-systems
Vetter and Microdermics Enter into a Strategic Cooperation Agreement to Develop Innovative Microneedle Drug Delivery Systems
Published on 31/05/2017, 14:00 | 30752hits
apceth-biopharma-appoints-dusan-kosijer-as-chief-financial-officer
apceth Biopharma Appoints Dusan Kosijer as Chief Financial Officer
Published on 31/05/2017, 10:30 | 31223hits
ce-mark-for-implandatas-eyemate-system-for-improved-monitoring-and-management-of-glaucoma-patients
CE Mark for Implandata's EYEMATE™ System for Improved Monitoring and Management of Glaucoma Patients
Published on 31/05/2017, 09:00 | 28712hits
inthera-bioscience-raises-chf-105-million-in-series-a-financing-round
Inthera Bioscience Raises CHF 10.5 Million in Series A Financing Round
Published on 30/05/2017, 09:15 | 30129hits
orchard-therapeutics-ltd-announces-a-manufacturing-services-agreement-with-pct-cell-therapy-services-llc
Orchard Therapeutics Ltd. Announces a Manufacturing Services Agreement with PCT Cell Therapy Services, LLC
Published on 30/05/2017, 09:00 | 30951hits
stago-group-acquires-hemosonics-llc
Stago Group Acquires HemoSonics LLC
Published on 26/05/2017, 11:00 | 30169hits
hookipa-biotech-announces-nature-communications-publication-showing-theratr-turns-cold-tumors-hot
Hookipa Biotech Announces Nature Communications Publication Showing TheraT® Turns Cold Tumors Hot
Published on 23/05/2017, 13:15 | 27277hits
new-high-performance-filtration-plates-from-biotage
New High Performance Filtration Plates from Biotage
Published on 22/05/2017, 15:30 | 28738hits
norwegian-study-confirms-the-potential-health-benefits-of-pressure-based-compression-in-accordance-with-sigmascreenings-sensitive-paddle-concept-for-mammography-equipment
Norwegian Study Confirms the Potential Health Benefits of Pressure Based Compression in Accordance with Sigmascreening’s Sensitive Paddle Concept for Mammography Equipment
Published on 19/05/2017, 09:00 | 30470hits
emperra-wins-the-2017-game-changers-award-for-digital-business-models
Emperra Wins the 2017 Game Changers Award for Digital Business Models
Published on 18/05/2017, 18:30 | 30397hits
new-mass-detector-for-flash-chromatography-from-biotage
New Mass Detector for Flash Chromatography from Biotage
Published on 17/05/2017, 11:00 | 30858hits
sartorius-stedim-biotech-partners-with-nova-biomedical-
Sartorius Stedim Biotech Partners with Nova Biomedical
Published on 16/05/2017, 14:00 | 29818hits
beactica-announces-glioblastoma-research-collaboration-with-uppsala-university-and-the-ddd-platform-at-scilifelab
Beactica Announces Glioblastoma Research Collaboration with Uppsala University and the DDD Platform at SciLifeLab
Published on 15/05/2017, 16:00 | 30599hits
cellgenix-appoints-leading-experts-to-scientific-advisory-board
CellGenix Appoints Leading Experts to Scientific Advisory Board
Published on 15/05/2017, 11:40 | 29986hits
biontech-announces-positive-results-of-an-international-reproducibility-study-with-mammatyperr
BioNTech Announces Positive Results of an International Reproducibility Study with MammaTyper®
Published on 15/05/2017, 11:00 | 26858hits
isarna-presents-positive-clinical-data-for-isth0036-in-advanced-glaucoma-and-preclinical-data-supportive-of-amddme-potential-at-arvo-2017-annual-conference
Isarna Presents Positive Clinical Data for ISTH0036 in Advanced Glaucoma and Preclinical Data Supportive of AMD/DME Potential at ARVO 2017 Annual Conference
Published on 12/05/2017, 09:00 | 27111hits
neurodigm-uses-tissue-repair-in-an-innovative-nerve-pain-model
NeuroDigm Uses Tissue Repair in an Innovative Nerve Pain Model
Published on 09/05/2017, 14:00 | 30054hits
biopharmaspec-announces-expansion-of-in-house-analytical-capabilities
BioPharmaSpec Announces Expansion of In-house Analytical Capabilities
Published on 04/05/2017, 14:30 | 31265hits
sartorius-stedim-biotech-launches-chemistry-testing-services
Sartorius Stedim Biotech Launches Chemistry Testing Services
Published on 04/05/2017, 10:30 | 29732hits
alzprotect-the-american-food-and-drug-administration-fda-has-granted-azp2006-the-orphan-drug-designation-for-the-treatment-of-progressive-supranuclear-palsy-psp
AlzProtect : The American Food and Drug Administration (FDA) Has Granted AZP2006 the Orphan Drug Designation for the Treatment of Progressive Supranuclear Palsy (PSP)
Published on 04/05/2017, 10:00 | 28250hits
hookipa-biotech-presents-positive-data-from-phase-1-first-in-human-trial-of-vaccine-against-cytomegalovirus
Hookipa Biotech Presents Positive Data from Phase 1 First-In-Human Trial of Vaccine Against Cytomegalovirus
Published on 28/04/2017, 11:45 | 32257hits
sartorius-stedim-biotech-introduces-new-biostat-strr-bioreactor-range
Sartorius Stedim Biotech Introduces New BIOSTAT STR® Bioreactor Range
Published on 24/04/2017, 13:15 | 70142hits
redhill-biopharma-announces-enrollment-of-last-patient-in-the-bekindar-phase-ii-study-for-ibs-d
RedHill Biopharma Announces Enrollment of Last Patient in the BEKINDA® Phase II Study for IBS-D
Published on 20/04/2017, 10:00 | 29671hits
polyganics-announces-enrollment-of-the-first-patient-in-its-protect-neuro-study
Polyganics Announces Enrollment of the First Patient in its PROTECT NEURO Study
Published on 19/04/2017, 09:00 | 33237hits
reinhard-kandera-appointed-chief-financial-officer-of-hookipa-biotech
Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech
Published on 18/04/2017, 14:45 | 75171hits
redhill-biopharma-receives-notice-of-allowance-for-two-additional-us-patents-covering-bekindar
RedHill Biopharma Receives Notice of Allowance for Two Additional U.S. Patents Covering BEKINDA®
Published on 12/04/2017, 22:15 | 79149hits
agendia-appoints-patrick-j-balthrop-sr-former-ceo-of-luminex-as-chairman
Agendia Appoints Patrick J. Balthrop Sr., Former CEO of Luminex, as Chairman
Published on 11/04/2017, 13:30 | 32428hits
ldc-and-sotio-enter-license-and-collaboration-agreement-for-first-in-class-cancer-metabolism-program
LDC and SOTIO Enter License and Collaboration Agreement for First-in-class Cancer Metabolism Program
Published on 11/04/2017, 11:15 | 30918hits
lifecodexx-and-charite-to-form-research-alliance-following-successful-clinical-proof-of-principle-for-molecular-genetic-based-preeclampsia-assay
LifeCodexx and Charité to Form Research Alliance Following Successful Clinical Proof-Of Principle for Molecular Genetic-Based Preeclampsia Assay
Published on 06/04/2017, 10:00 | 30558hits
asceneuron-receives-regulatory-approval-for-phase-i-healthy-volunteer-study-of-oral-tau-inhibitor
Asceneuron Receives Regulatory Approval for Phase I Healthy Volunteer Study of Oral Tau Inhibitor
Published on 05/04/2017, 14:00 | 83403hits
redhill-biopharma-announces-exclusive-us-license-from-entera-health-for-commercial-gi-product-enteragamr
RedHill Biopharma Announces Exclusive U.S. License from Entera Health for Commercial GI Product EnteraGam®
Published on 04/04/2017, 12:30 | 75908hits
redhill-biopharma-receives-fda-orphan-drug-designation-for-yelivar-for-the-treatment-of-cholangiocarcinoma
RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma
Published on 04/04/2017, 12:00 | 29577hits
nbe-therapeutics-expands-board-of-directors-by-the-appointment-of-hans-peter-gerber
NBE-Therapeutics Expands Board of Directors by the Appointment of Hans-Peter Gerber
Published on 03/04/2017, 16:00 | 32284hits
australias-bionic-vision-technologies-raises-us18-million-au235-m-to-develop-bionic-eye-for-global-markets
Australia’s Bionic Vision Technologies Raises USD18 Million (AUD23.5 M) to Develop ‘Bionic Eye’ for Global Markets
Published on 03/04/2017, 10:00 | 28711hits
imanova-receives-p1m-award-from-the-mrc-to-develop-early-markers-of-dementia-the-mind-maps-study
Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia – the MIND-MAPS Study
Published on 31/03/2017, 08:00 | 30080hits
calypso-biotech-licenses-caly-001-best-in-class-anti-mmp-9-antibody-to-ea-pharma
Calypso Biotech Licenses CALY-001 Best-In-Class Anti-MMP-9 Antibody to EA Pharma
Published on 28/03/2017, 16:05 | 31590hits
vetters-dr-claudia-roth-is-appointed-to-the-fraunhofer-advisory-board
Vetter’s Dr. Claudia Roth is Appointed to the Fraunhofer Advisory Board
Published on 28/03/2017, 13:15 | 31161hits
selvita-and-menarini-group-announce-global-license-agreement-for-clinical-stage-oncology-drug-pimflt3-inhibitor-sel24
Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24
Published on 27/03/2017, 16:45 | 28130hits
Chemotherapy as a Tablet Instead of an Intravenous Infusion: A Benefit for the Patient
Published on 21/03/2017, 14:45 | 48692hits
redhill-biopharma-announces-first-patient-dosed-in-the-open-label-extension-study-to-the-phase-iii-study-with-rhb-104-for-crohns-disease
RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III Study with RHB-104 for Crohn’s Disease
Published on 21/03/2017, 09:15 | 30087hits
european-group-on-tumour-markers-egtm-updated-guidelines-recommend-agendias-mammaprintr-test-with-highest-level-1a-clinical-evidence
European Group on Tumour Markers (EGTM) Updated Guidelines Recommend Agendia’s MammaPrint® Test with Highest Level 1A Clinical Evidence
Published on 17/03/2017, 11:50 | 28610hits
selvita-announces-first-patient-dosed-in-phase-iii-clinical-trial-of-sel24-in-acute-myeloid-leukemia
Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia
Published on 17/03/2017, 09:45 | 28803hits
genomic-health-unveils-a-wealth-of-data-for-the-oncotype-dxr-breast-cancer-test-reinforcing-its-value-in-improving-patient-outcomes-and-leading-to-more-cost-effective-management
Genomic Health Unveils a Wealth of Data for the Oncotype DX® Breast Cancer Test, Reinforcing Its Value in Improving Patient Outcomes and Leading to More Cost-Effective Management
Published on 13/03/2017, 23:45 | 38654hits
cambridge-based-astex-pharmaceuticals-celebrates-as-cancer-drug-receives-us-marketing-approval
Cambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval
Published on 13/03/2017, 14:00 | 30058hits
selvita-to-present-new-data-from-its-oncology-programs-at-the-upcoming-aacr-annual-meeting-2017
Selvita to Present New Data from its Oncology Programs at the Upcoming AACR Annual Meeting 2017

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
Ok